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Abstract
Characterization of In-Situ Curing PVA-PEG Hydrogels for Nucleus Pulposus 
Replacement 
Kristin Benjamin Kita
Anthony M. Lowman, Ph.D.
Poly(vinyl alcohol) / poly(ethylene glycol) blend formulations are evaluated as an in 
situ forming gel system.  The system will provide a minimally invasive approach to 
nucleus replacement, whereby a cavity formed in the intervertebral disc post-
denucleation is filled via an injectable solution that solidifies to function as prosthetic 
nucleus pulposus tissue, restoring height, and hydration to the disc, as well as 
correcting the biomechanics of the spine.
PVA/PEG gels have an inherent system incompatibility that results in the formation 
of a two phase region, where a water rich supernatant and a polymer rich gel phase 
form.  Systems of dense gels have previously had no simple analytical means for 
separation of the two similar polymers, particularly at the high viscosities required for 
this specific application.  
1
H-NMR analytical techniques are developed for 
preparation of a %w/w phase diagram.  Understanding of possible compositional 
space enables definition of swelling and stability characteristics for the final gel as it 
relates to composition.  Changes in PEG molecular weight are shown to affect
swelling and stability in gels.  Upon rheological analysis, a change in the resulting 
system network with the incorporation of varying types of PVA and PEG is evident.  
Concentrated gels are shown to display a high temperature reduction in viscosity.  
This effect is shown to be dependent on molecular weight of the PEG component and 
xiii
gel composition.  Similarly, there is a requirement that the system have a low 
viscosity during the sol stage that shown to be satisfied due to system incompatibility 
and plasticization effects.  
xiv
1CHAPTER 1: INTRODUCTION
Intervertebral disc degeneration results from a variety of sources.  Whether caused by 
nutritive, genetic, age or systemic sources, the intervertebral disc is often implicated 
as the source of back pain.  The implantation of a prosthetic nucleus pulposus tissue 
has been proposed as a means to restore the biomechanics of the disc, as well as a 
treatment to relieve pain resulting from degenerated discs.   
Nucleus tissue consists of 70-90% water [1].  The intervertebral disc relies on 
diffusive and convective processes to transmit nutrients to the area.  It is known that 
the degenerative process results in a reduction in water content local to the area [2].
As diffusion is reduced in degenerated tissues, nutrient supply to discs is similarly 
reduced.  Polyvinyl alcohol hydrogels are commonly chosen for nucleus pulposus 
implants for their biocompatibility, as well as their ability to retain water [3].  In this 
manner, hydrophilic materials are currently being investigated as a way to maintain 
critical swelling pressure within the disc through the retention of water, much in a 
way similar to nucleus tissue.
Previous research has found that incompatibilities between poly(vinyl alcohol) and 
poly(ethylene glycol) result in a phase separation that produces a phase concentrated 
in polymer, as well as a water rich supernatant phase [4].  Further research shows 
plasticization and interference of vinyl alcohol units from the incorporation of PEG
[5].  
2The production of a gel phase, as concentrated via the phase separation mechanism 
described by Inamura is evaluated for gelation characteristics using temperature 
controlled rheometry studies.  It has also been shown that a transition exists for 
poly(vinyl alcohol) in salt solutions as well as low degree of hydrolysis PVA, where 
viscosity reduction at higher temperatures occurs as a result of reduction in polymer-
solvent interactions [6].  It is through these temperature-dependent plasticization 
phenomena that the material is made flowable at elevated temperature.
The primary objective of this thesis is to address the need for an in situ forming 
biomaterial that effectively treats disc degeneration via nucleus pulposus replacement 
with implantation of a biocompatible construct.  The construct design is intended to 
exceed the gelation characteristics of neat PVA gels, via the incorporation of a second 
polymer component.  Crosslinking is obtained via physical means, using the natural 
hydrogen bonding and crystallization nature of the material to impart stability, in 
order to avoid any toxic crosslinking compounds.  The system provides a minimally 
invasive approach to nucleus replacement, whereby a cavity formed in the 
intervertebral disc is filled via an injectable solution that solidifies to function as 
prosthetic nucleus pulposus tissue, restoring height, and hydration to the disc, as well 
as correcting the biomechanics of the spine.
  
The following chapters study the feasibility of the PVA and PEG system through a 
variety of characteristics necessary for a suitable nucleus replacement.  In particular, 
the thermal gelation profile is described, such as would be observed when cooling to 
3the gelled state upon delivery and implantation.  Effects of swelling and equilibrium 
water content as a result of the physiologic environment of the cavity created for 
implantation are described, as well as the resulting stability.  Understanding of 
compositional space is necessary for formulation, and structured via the creation of a 
ternary phase diagram for a given formulation system.  Further, a technique using 
nuclear magnetic resonance for the chemical separation of PVA and PEG is 
developed in order to create such a diagram for the target concentrated formulations.  
The scientific contribution, through the completion of this work, is as follows:
 Quantification the phase behavior of PVA/PEG gel systems conducive to nucleus 
replacement 
 Characterization of the thermal and time dependent response of gelation behavior 
across PVA/PEG formulation systems (molecular weight and composition affects 
on gelation)  
 Identification and quantification of the response of different PVA/PEG systems 
(in particular, molecular weights and relative amounts of components) to a 
physiologic osmotic environment
 Separation of PVA and PEG via a reliable chemical analytical technique (NMR)
 Relation of PVA/PEG plasticization to melt rheology across formulation systems
4CHAPTER 2: BACKGROUND
2.1 Spine Anatomy
The spine is a curved flexible column positioned in the median line at the posterior 
portion of the trunk (see Figure 2.1) [7]. The spinal column is formed from the 
junction of thirty-three vertebrae, which are bones situated along the spine.  The 
structural and biomechanical system of the spine is complex, and consists of a variety 
of elements working in concert, in order to provide the correct function.  
Intervertebral discs provide joints for the system, the movement and loads also being 
supported by articulating surfaces on the bones (facets).   Viewed laterally, there are 
four curves in a normal spine.  Curves in the cervical and lumbar regions are convex 
anteriorly, whereas curves in the thoracic and sacral are convex posteriorly.  
Curvature in the thoracic region is structural, whereas the lumbar and cervical curves 
result from the wedge shape to the discs.  The overall curved shape of the spine is for 
both flexibility and shock absorption [8].
The regions of the spine are cervical, thoracic, lumbar, sacral and coccygeal, the 
cervical vertebrae being the smallest, and beginning at the base of the skull and 
extending seven units to the twelve thoracic vertebrae.  Past the thoracic vertebrae, 
are the five lumbar vertebrae.  The sacrum and coccyx make up the caudal, or tail end 
of the spine [7].  
5The vertebrae are made up of an anterior solid segment (vertebral body) and a 
posterior arch.  The vertebral body consists of a cortical bone perimeter surrounding a 
core of cancellous bone.  Understanding of the relative percentage of load carrying 
capacity of either type of bone varies widely in different literature [9].  The posterior 
arch consists of lamina, pedicles, and several processes.  A spinous process is situated 
along the medial line when viewed posteriorly.  Superior and inferior articulating 
processes face both upward and downward from the posterior arc.  Existing for all 
spinal units, but most visibly in the dorsal and lumbar spine, two transverse processes 
extend outward at either side of the posterior arch.  Facet joints, or articulating 
processes play a large role in the torsional stiffness of the spine.  
There are two functions to the intervertebral disc, to impart flexibility (i.e. flexion, 
extension, rotation, lateral bending, and intersegmental mobility) as well as to be load 
bearing. The thickness of discs is greatest in the lumbar and cervical regions, where 
there is the most vertebral movement [10].  It has been found by Nachemsen, that the
loads may be three times the weight of the trunk when the lumbar disc is in the sitting 
position [8, 11]
The intervertebral disc consists of an outer ring of fibrous tissue (the annulus 
fibrosus) surrounding a soft, gelatinous core (the nucleus pulposus) (see Figure 2.2).  
At the boundary of the intervertebral disc and vertebrae are endplates consisting of 
hyaline cartilage.  The annulus fibrosus is made up of 90 layered sheets of collagen 
fibrils [10].  The fibers are arranged in a helical fashion, running in opposite 
6directions in adjacent layers[8].  Changes in morphology of the annulus have been 
known to occur with aging.   
The nucleus pulposus consists of thin fibers in a mucoprotein gel [8].  Negatively 
charged proteoglycans make up 30-50% of the dry weight of the nucleus tissue and 
function to absorb and retain water [12].  The main proteoglycan is aggrecan, which 
is made up of many glycosaminoglycan molecules in a brushlike structure [13].  The 
nucleus is described as having a pseudochondral cellular makeup.  The extracellular 
matrix of nuclear tissue consists primarily of Type I and Type II proteoglycans 
(keratin sulfate and chondroitin) in fluid [14].  Water content of nuclear material is 
typically from 70 to 90% and is known to decrease with age.  Monitoring of water 
content can further be performed via MRI.   The nucleus pulposus in early life is 
derived from notochord cells which are no longer present in early adulthood, but 
replaced by cells similar to load bearing cartilage [1].  
The spinal cord runs from the brain down the length of the spine, within the vertebral 
foramen, which is the region within the posterior arch of the vertebra.  The spinal 
cord ends at the first lumbar segment where it splits into the conus medullaris, a 
group of nerves which enervate the lower portion of the body.  Each vertebral 
segment has two nerves extending from the spinal cord at either side, which exit to 
enervate different portions of the body.
7Innervation specific to intervertebral discs remains to be fully understood [10].  
Whereas no nerves are thought to be in the inner annulus or nucleus, free nerve 
endings have been identified in the outer annulus.  The positions of the exiting nerve 
roots in a disc are as in Figure 2.2.
There are seven ligaments for the region between C2 and the sacrum:  Loads are best 
carried in the direction of the fibers in these ligaments.  Ligaments function as to 
balance loads applied to the spine and provide tensile resistance.  Loads are 
transferred from bone to bone via these structures. The anterior longitudinal ligament 
is attached to the anterior surfaces from the atlas to the sacrum.  This ligament is 
attached to vertebrae, but not as tightly to annular fibers.  The posterior longitudinal 
ligament runs down the posterior surface of the spine, covering the dens and 
transverse ligament.  Intertransverse ligaments connect transverse processes of the 
thoracic spine with muscles in the back.  These have little significance mechanically 
in the lumbar region due to size.  Capsular ligaments are attached perpendicular to 
facets, in particular for allowing flexion and enabling stability in the cervical region.  
The ligamenta flava connect adjacent vertebrae along the inner portion of the lamina.  
A tension in the ligamenta flava provides stability for the spine.  Adjacent vertebrae 
are attached at the processes by the interspinous ligaments.  Supraspinous ligaments 
also continue down the tips of the processes [8].  Methods of failure of these 
ligaments are typically within the ligament or at the point of attachment to bone.  
   
82.1.1 Physiologic Environment of the Nuclear Cavity
The intervertebral disc provides a load-bearing joint for adjacent vertebrae in the 
spine.  The intervertebral disc is avascular, meaning it cannot rely on blood flow to 
directly provide hydration and nutrients to the nucleus tissue.  The tissue remains 
hydrated via diffusion through the endplate cartilage.  The resulting hydration of 
nucleus material is confined by the relatively impermeable annulus as a swelling 
force.   The disc responds to compressive stress by exuding water from the nucleus, 
outward through the annulus [15].   In a typical diurnal cycle, nucleus tissue may 
express approximately 25% of its fluid.  Changes in percentage of fluid result in 
osmolality changes.  Swelling and deformation of nucleus tissue occurs as a result of 
hydraulic permeability at the endplates which changes with loading [14].  
Because the intervertebral disc is avascular, cells must derive nutrients via diffusion.  
The outer annulus is supplied via blood vessels at the disc perimeter.  In contrast, the 
nearby vertebral bodies are very vascular.  The annulus, nucleus and transitional zone 
are each fed by different arteries within the vertebral body.  The inner annulus and 
nucleus are supplied by a capillary bed in the vertebral body which terminates at the 
cartilaginous endplate [16].  Nutrients are supplied through the endplate via flow-
dependent diffusive and flow-independent convective processes for the fluid.  
Diffusion is also necessary for the removal of the products of cell metabolism.  
A major factor in the regulation of the physicochemical environment of nucleus cells 
is aggrecan concentration [16].  The presence of the negatively charged proteoglycans 
9within the aggrecan allows for a tight effective pore size in order to entrap water.  
Positively charged ions, such as sodium thus are found in high concentration within 
this region, in comparison to plasma [16].  As a result of this network, there is a 
partitioning in diffusing solutes that occurs [17].  Proteoglycan content strongly 
affects the size of these pores as well as the osmotic pressure of the nuclear cavity.  
The proper function of a disc is therefore dependent on proteoglycan content. 
Model systems have been developed by Ogston and Wells for estimating hip cartilage
osmotic properties.  A system developed by Urban using PEG saline solutions is
similarly described.  Solution concentrations of PEG are related to osmotic pressure 
using the following equation [18].
π = RT  ( c/ M + Bc
2
 + Cc
3
 + … )    
B = 2.59 * 10
-3
C = 13.5 * 10
-3
M: number average molecular weight
R: 8.314 J mol/°K
2.1.2 Biomechanics of the Spine
The spine has three main functions in biomechanics, to transfer weights and bending 
moments of the upper portion of the body and head, to allow for the bending motions 
of these portions, and last to protect the spinal cord [8].  
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Intervertebral discs in the spine allow for many types of mechanical support, in 
particular the bending and twisting and support for compressive loads resulting from 
the weight of the body [19].  The physiologic modes of flexion, extension and lateral 
bending also produce tensile forces on the disc as well [8].  Direct compressive 
loading in a neutral position results in compressive stresses in the nucleus and tensile 
stresses in the annular fibers [8].   See Figure 2.3.  Across a vertebral unit, a 
compressive load is applied axially from one endplate across the nucleus and annulus, 
to the other endplate.  A compressive load applied in a healthy disc results in 
transmission to the nucleus tissue, which bulges outward pushing the annular ring 
outward and creating tension in the annular fibers.   The helical orientation of the 
fibers results in axial and circumferential stresses.  In a degenerated disc the nucleus 
is dehydrated, and not capable of generating the required fluid pressure. The load is 
transmitted in this state primarily through the annulus at the periphery instead, 
resulting in compressive stresses on inner fibers.   As a result of Poisson’s effect, 
there is a bulge to the disc upon compression and a contraction when the disc is in 
tension.  
In bending, the disc is subjected to tension on the side that is convex and compression 
on the inner, or concave side.  Stresses are greatest in compression on the innermost 
side of bending and are greatest in tension on the outermost side of bending.  In axial 
torsion, the degree of stress has much to do with the degenerate state of the disc, as 
well as the condition of the posterior elements.  Shirazi-Adl et al found that removal 
11
of posterior elements (posterior arch, including lamina and facets) increased annular 
fiber stresses upon torsion.  There was similarly a decrease in stress in torsion, with a 
decrease in intradiscal pressure [20].
Data from most studies on functional biomechanics has been obtained from cadaver 
discs.  There are few studies measuring in vivo loads [8]. Early work by Nachemson 
and Morris uses the insertion of transducers into the disc space of cadaveric 
functional spinal units in order to approximate in vivo loading [11].  Another study by 
Wilke measures intradiscal pressure, via the insertion of a pressure transducer into the 
non-degenerated disc of a living subject [21].  Data was compared with Nachemsen 
and Morris’ approximation.  Pressures were reported to be highest for flexion while 
lifting a 20Kg weight, and were measured at 2.3MPa.  Other significant pressures 
included standing flexed forward at 1.1MPa.  It was shown from the study that 
activities had a direct affect on intradiscal pressure.  Pressure in the recumbent state 
has shown to be 0.1 to 0.2MPa.  The range of pressures in the spine during normal 
activity may reach 1-3MPa [13].
Because of changes in water content that occur with loading, loading rate further has 
been shown to affect structural stiffness of the disc.  The disc is described as behaving 
in a viscoelastic manner. This can be described as a time-dependent response to 
loading.  Load-displacement curves are thus different, when loads are applied over 
different time-scales [8].  Stiffness will increase with loading rate.  The disc expresses 
fluid upon application of a load.  Since fluid outflow is rate dependent, stiffness 
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increases as fluid outflow becomes more difficult [22].   Pressurization of the disc is 
necessary for proper uniform distribution of loads between disc and endplate.  With 
degeneration, the ability for discs to support compressive loads is hindered by a 
condition which decreases fluid flow into nucleus tissue, or increasing flow through 
the annulus [23].  
2.2 Degenerative Disc Disease
Chronic lower back pain affects over 5 million persons in the USA alone [24]. 
Although the causes of back pain are not currently completely understood, 
degenerative disc disease is believed to play a significant role [25].  Degeneration in 
the intervertebral disc often results from mechanical factors as well as nutrition,
systemic (cigarette smoking, for example) or genetic sources.  Degeneration may 
begin as early as the first decade of life for males and the second decade for females.  
Whether or not a degenerated disc is truly the source of back pain remains a subject 
of controversy. Further, any correlation between degenerated segments and low back 
pain is yet to be determined.  Back pain may be due to mechanical factors, or disease, 
as in inflammatory disease such as rheumatoid arthritis or ankylosing spondylitis 
[26].  Degeneration of discs is believed to be the source of stenosis, herniation of the 
nucleus pulposus, and segmental instability [10]. 
There is a natural change in the disc with aging. Environmental and genetic causes 
can accelerate these changes.  8 of 10 adults will experience some form of back pain 
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in their lives.  Along with low back pain, DDD is the greatest source of lost wages 
annually, and is the third leading cause of disability, which translates to 50-100 
billion dollars annually in costs [10, 27].  Most will not require formal treatment [2].  
In cases of persistent pain, surgery may be indicated [28].  
Based on the vascular configuration local to the disc, inner arteries are affected by 
immobility or fusion at the vertebral joint.  There is a corresponding decrease in 
blood supply to the central nucleus with age induced degeneration.  Calcification of 
the cartilage endplates also may inhibit diffusion and nutrient flow.  A lack of 
nutrition to the disc may lead to decreased function in cells and ultimately cell death, 
which is the source of degeneration in the disc [10].  The disease progresses as the 
proper water flow and nutrients are inhibited, producing dehydration of nucleus 
material which affects the load distribution.  With the resulting loss of motion and 
disc height, pain is typically experienced, particularly in later stages of degeneration 
[23].  
Age related disc degeneration can be described as follows:  There is a decrease in the 
amount of viable cells in the nucleus which leads to decreased water and 
proteoglycan content.  Nucleus tissue can be observed to become less transparent at 
this stage.  Though cells do not contribute directly to the mechanical properties of the 
disc they produce extracellular matrix, which does [16]. As a result, a decrease in 
number of cells forces cells to maintain greater amounts of extracellular matrix [19].  
Decreased proteoglycan concentration and water concentration leads to a volume loss 
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in nucleus pulposus tissue, which in turn leads to a decrease in nuclear pressure.  
Severely degenerated discs exhibit close to no pressure from the nucleus whatsoever, 
forcing the annulus, as well as the posterior elements to bear loads [29].  The annulus 
exhibits degeneration along with this change in nuclear material.  There is a further 
loss in the gelatinous consistency, annular fibers become more coarse, and fissures 
begin to form on the surface of the disc.  When the amount of degeneration is severe, 
nucleus and annulus material can not be distinguished from each other.  Nucleus 
pulposus herniates at this stage, since degenerated discs can no longer hold the 
nucleus material [10].  
2.2.1 Prolapse of Nucleus Tissue onto Pain Generating Sources 
Loads of concern for prolapse of nucleus material from discs are divided into short 
duration-high amplitude loads and long duration-low amplitude loads.  These two 
classes are significant when taking into account the viscoelastic nature of the disc, in 
particular, creep and relaxation behavior, and sensitivity of the disc to rate of loading.  
Structural damage generated by short duration/high amplitude load is often 
irreparable when the failure stress of the segment is generated, whereas longer 
duration/low amplitude loads are limited by fatigue characteristics for tear and growth 
of fissures [8].   
It is known that sudden injury may result in disc prolapse.  Incidents of bending or 
lifting are known to precede reports of low back pain and sciatica.  Evidence also 
suggests that prolapse may be slow, as in through a gradual tear and leak of nucleus 
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material [30].  In vitro testing has further shown that it is difficult to produce 
herniations of nucleus material from direct compressive loading of a vertebral unit 
[22].  More complex bending profiles are required.  The combination of compression 
loads with flexion and lateral bend has been proposed as a possible mechanism.  In a 
study by Simunic, evidence suggests that prolapse may be generated by loading in a 
flexed state.  It was similarly observed epidemiologically that persons with 
occupations which involved repetitive bending and lifting had a 300 to 600% 
increased risk of herniation [22].
Though acutely prolapsed discs are regarded by most as a definitive source of pain, 
the sources of all pain remain unproven.  A contained disc is much more difficult to 
diagnose [31].  The intervertebral disc is often implicated in the discussion of pain 
generating sources in non-prolapsed states, as well.  The initial stimulus is described 
as being from abnormal motion, vibrations, forces and repetitive loading.  The result
of the stimulus may be inflammation, or infection or structural or material changes 
that relay the pain sensation to nociceptive sensors [32].  The increase in blood 
pressure in bone has also been seen to result in pain generation.  Pain may be 
generated by any muscle or tendon structures being strained, sprained or ruptured [8].  
Pain receptors are known to be in both the anterior and posterior ligaments, as well as 
the interspinous ligaments, periosteum, fascia and blood vessels of the vertebrae, 
posterior annular fibers as well as paravertebral musculature, among other sources 
[33].  It has been argued that the non-herniated disc is a major source of back pain 
[8].  As a result of the inconsistencies and difficulties in the diagnosis of pain-
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generating degenerative states, the identification of treatment techniques have been 
equally difficult [34].
2.3 Clinical Treatment Options
2.3.1 Conservative Treatment
Conservative measures remain the treatment for the majority of incidences of back 
pain [35]. In this case, pain and inflammation is typically mitigated via physical 
therapy, injections and medications [36]. With time, herniated disc fragments are 
often seen to reduce in size, coupled with a decrease in symptoms [35].  Apart from 
conservative care, results which may depend upon severity of the condition of the 
patient, surgical methods may be necessary.  Since spasms have been often thought as 
pain generating sources, muscle relaxants and massage have similarly frequently been 
administered to treat these conditions [8].
2.3.2 Surgical Treatment
Surgical procedures are indicated when conservative care fails, or in cases of 
instability that threatens neural elements.  The two current leading surgical treatments 
are discectomy and disc arthrodesis (fusion) [37].  Fusion requires affixing upper and 
lower vertebrae via rods and spacers that promote bone to adjoin vertebral segments.  
The procedure is incredibly destructive and results in loss of motion and a change in 
stress distribution for fused levels [38].  
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Certain needle treatments also exist in the form of both pain control injections, as 
well as IntraDiscal Electrothermal Therapy (IDET, by ORATEC) which is a 
percutaneous procedure where a catheter with a heated tip is inserted into the disc.  
Heating continues for 15 minutes, with the intention of removing symptoms of 
degenerative disc disease in the lower back.  IDET is an early stage treatment targeted 
toward pain generated in the disc, with minimal collapse and corresponding annular 
tears [34].  
2.3.2.1 Microdiscectomy 
In cases where conservative care and medication are ineffective in relieving 
symptoms of low back pain with sciatica, tissue is excised from the disc to clear 
herniated material impinging on local nerve roots [39].  The procedure typically 
involves first the removal of a small portion of bony material from the back of the 
vertebra in order to locate the herniation and nerve impingement.  Minimally invasive 
techniques are often employed for the removal of tissue.  The discectomy procedure 
may be performed using mechanical means or a chemonucleolysis agent, such as 
chemopapain.  Mechanical methods include the use of rongeurs to physically cut and 
remove tissue (see Figure 2.4).  Other methods include the use of the Nucleotome, 
which has a 2mm diameter probe fitted with a guillotine to slice and remove tissue 
[39], or Hydrocision which involves use of a high pressure water jet to cut and 
remove material.  Techniques useful for nucleus pulposus removal for discectomy 
procedures are further useful for the creation of a cavity for nucleus replacement.  
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This removal of the nucleus tissue, such as in a discectomy results in a gradual 
decrease in disc height [2] which may result in further complications.
Removal of nucleus tissue further alters the biomechanics of the disc.  Motion of the 
annular fibers is changed to become more disjointed.  For an intact nucleus, motion 
results in bulging outward in both the inward and outward regions [40], in contrast, 
for a denucleated annulus there is a bulging of the annular material that pushes the
outward annulus further out and the inward annulus further inward leading to 
degeneration.  Additional stress on the facets from degeneration may lead to further 
progression of degeneration. 
There is an increase in mobility with nucleotomy.  In a study by Eysel, the removal of 
5-6 grams of nucleus tissue resulted in 38-100% increase in mobility for the cadaveric 
spinal segment being tested.  It has been suggested that instability due to nucleotomy 
is better defined as abnormal mobility, i.e. a greater range of motion when compared 
with adjacent vertebrae [41].   
There is a significant reherniation rate associated with discectomy.  It has further been 
shown that even removal of a portion of the nucleus may increase the rate of further 
degeneration.  It has further been shown in an animal study that the reinsertion of a 
spacer will delay further disc degeneration, including the nucleus, annulus, and end 
plate [10].
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2.3.2.2 Fusion
The current most important surgical procedure in spine care is the technique of spinal 
fusion.  The procedure was first introduced in 1911 by Albee and Hibbs [8].  Hibbs 
was reported to have removed spinous processes and achieved fusion through the 
construction of a bridge of bone, once this piece of bone was inserted caudally to 
contact the inferior vertebral processes and sutured into position [42].  By such 
methods, fusion limits impingement on pain generating structures by fixing vertebrae 
into position via arthrodesis, where bone is induced to grow across the disc space, 
forming an immobile union between the two bones.  Reasons for fusion include to 
provide support and stability, to prevent the progression of deformity, and to alleviate 
or eliminate pain [8].
Early treatments reported by Cloward in 1952 used ilium bone graft in order to 
achieve fusion through insertion between vertebrae.  From years of study, Cloward 
also reported the effectiveness of using auto and allograft material for these spacers 
[42].  Current technologies for spacers include synthetic materials (PEEK, titanium, 
and others) as well as allograft and autograft (in particular from the iliac crest of the 
hip) and are typically inserted between vertebrae as part of this procedure, as support 
for the fusion and for bone to grow in and around, in particular in conjunction with 
anterior plates and also with posterior fixation.  Spacers also have been packed with 
bone growth protein to further promote fusion.  In situ polymerizing methyl 
methacrylate has also been considered for use as a portion of a fusion construct.    
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In the early 1980s Steffee popularized the use of screws through the pedicle portion 
of the vertebra, by employing titanium cancellous bone screws in conjunction with a 
standard AO plate.  Good results (clinical rating of 4 out of 5) were reported from 
from 89% of the 120 patients that received the system [42].  Currently, rods and 
screws typically are employed as a means to immobilize and stabilize vertebrae, until 
fusion can occur (see Figure 2.5).  In addition to pedicle screws and rods, which are 
common for posterior and some lateral approaches, typical methods for securing this 
fixation for lumbar procedures are the use of plates (Synthes Antegra T, Anterior 
Thoracolumbar Locking Plate – ATLP) and/or bone graft containing cages (Synthes 
Zero-P, Medtronic LT-CAGE) from the anterior.  Attention by surgeons is typically 
paid to indications for surgery and anatomic procedural aspects, as well as to 
postoperative care, for the choice of a surgical construct [8].
Current procedures of fusion vary based on type and direction of access to the spine, 
as well as the methods for achieving the fusion.  Lumbar fusion is the most common, 
since the greatest amount of weight is on the lumbar segments, causing more frequent 
degeneration.  In lumbar fusion, access routes are posterior (Posterior Lumbar 
Interbody Fusion, or PLIF), anterior through the abdomen (Anterior Lumbar 
Interbody Fusion or ALIF), as well as Direct Lateral (DLIF) and Transforaminal 
Lumbar Interbody Fusion (TLIF), which is an oblique posterior access through the 
foramen.
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Bone morphogenetic protein (BMP) occurs naturally in bone and is responsible for 
bone regeneration.  Early studies performed by Urist showed that demineralized 
cancellous bone induced bone growth in rats.  Work by Urist ultimately allowed to 
identify the protein. BMPs are now known to induce the differentiation of 
mesenchymal stem cells (preosteoblasts) into osteoblasts.  Demineralized bone matrix 
(DBM) is similarly used for the small quantities of BMPs present.  The production of 
DBM is through the acid treatment of bone in order to remove the minerals.  In order 
to improve handling of the material, DBM is often mixed with other materials such as
carboxymethylcellulose, glycerol, hyaluronic acid or gelatin [43].  Hydroxyapatite 
(HA) is a family of calcium orthophosphates.  It constitutes the inorganic component 
of bone and is subsequently very biocompatible.  Hydroxyapatite structures such as 
coral and converted forms of coral, as well as tricalcium phosphate, a less crystalline 
form of hydroxyapatite have been used in fusions since the 1980s [43].
Segments adjacent to fused levels experience increased stress, excessive motion, 
stenosis as well as even fracture dislocation.  Degenerative changes are also common 
in adjacent segments [8]. 
There is an argument that persists for advancements in alternatives to fusion 
procedures.  It is believed that treatment with a fusion is only desirable over the short-
term, because of the development of problems in adjacent levels [27].  The proper 
motion of the disc is not preserved [10] and biomechanical studies have shown that 
more rigid fusion devices accelerate degeneration [28].  Further, in recent history,
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arthrodesis for synovial joints has reduced considerably in favor of the motion sparing 
joint replacement techniques [10].  
Fusion is understood to lead to degeneration of adjacent levels, as they attempt to 
compensate for the loss in biomechanics [37].  Discectomy, also results in a 
destabilization of the intervertebral disc which may lead to further degeneration [23].  
Upon review of the current treatment options, it is apparent that early stage 
procedures currently do not exist to halt the degenerative process.  Current 
developments of treating diseased levels of the spine look to replacement of a total 
disc via a prosthetic joint (e.g. Prodisc or Charité) [44], or the potentially less 
invasive route of replacement of nucleus tissue, to rebuild a disc with a competent 
annulus.
2.3.2.3 Total Disc Replacement
The concept of an artificial disc is well over 40 years old [34, 45].  Artificial disc 
replacement involves replacement of the entire disc or a portion using an apparatus 
that provides a joint often coupled with a means for fixing that joint to the vertebral 
body. Replacement of only the nucleus tissue is described in the following section.  
Other proposed options for disc replacement are the implantation of allograft discs, 
including endplates, nucleus and annulus.  Only artificial devices have currently
reached clinical trials however [10]. 
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Early devices included one by Fernstrom which consisted of a ball bearing introduced 
to the disc space from the anterior.  Results for patients varied, some were 
hypermobile, while others resulted in fusion.  Migration of the implant out of the disc 
space as well as settling into the spongiosa were further complications with the device 
for the period where it was in use [28].
A Total Disc Replacement that consists of two plates attached by a central joint has 
been developed, as shown in Figure 2.6.  Two plates with a posterior hinge & two 
pairs of springs which provided the basis for Marnay’s design.  Marnay designed a 
ball joint which enabled three rotations, however since the center of rotation was not 
mobilized no translation was possible, resulting in shear stress for each of three 
translations.  Charite III (Depuy) had a two segment nucleus with a double joint but 
had a number of clinical complications.  Depuy had similarly developed Acroflex
(see Figure 2.7), a total disc with titanium endplates and a rubber nucleus. Acroflex
was implanted into six patients.  Four patients reported satisfactory results with the 
device, whereas one patient did not experience pain relief and another patient needed 
the implant removed and the vertebrae fused due to device failure.  Potential 
problems with toxicity in the rubber led to a redesign [28].
NuVasive is currently running clinical studies on its XL TDR, lateral access total disc 
replacement.  The lateral access technique for implantation is intended to provide for 
a minimally disruptive procedure, restoring disc height and maintaining motion.  
Some potential benefits of the lateral approach are the avoidance of vascular, 
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intestinal, and ureteral injury, as well as the avoidance of major bleeding risks of the 
other approaches. Insertion of a total disc replacement is not without its 
complications, particularly in the lumbar spine, where positioning of a relatively 
sharp metal device must be done in the immediate vicinity of blood vessels [41]. 
  
2.3.2.4 Regeneration
The alternative to disc replacement is disc regeneration, which may include 
regeneration of nucleus tissue, annulus tissue or both [10].  Nuvasive has considered 
chymopapain, a chemonucleolysis agent as a means to initiate nucleus pulposus 
regeneration. 
2.3.3 Nucleus Replacement Technologies
Current technologies for total disc replacement require excision of the majority of the 
disc, whereas an alternative approach that has been in development in recent years 
involves removal of the soft inner nucleus pulposus tissue central to the disc and 
replacement with a device for restoring the physiologic, viscoelastic, and 
biomechanical characteristics [34].  Implantation is geared toward slowing the 
degenerative cascade, with the intention of postponing or eliminating the need for a 
spinal fusion surgery [2].  Materials which form in situ within the body have been 
considered to fill the space that has been created within the disc.  Nucleus 
replacement exists as a potential treatment where, by delivering a prosthetic nucleus, 
25
the length and tension of annular fibers are restored, providing stability and restoring 
height to the disc, subsequently mitigating the degenerative process [3, 34, 37].  
A potential indication for nucleus pulposus replacement is severe lumbar 
degenerative disc disease which has not improved based on a six month nonoperative 
care. Disc degeneration is indicated with 10-50% loss of disc height, without 
fissuring.  MRI should show an early stage of degeneration without severe modic 
changes or facet arthrosis [2].
Current technologies for nucleus replacement similarly have undesirable aspects.  
Many require invasive procedures or toxic crosslinking agents.  The earliest nucleus 
replacement techniques (late 1950’s/early 1960’s) involved the injection of 
polymethylmethacrylate into the space formed from a nucleotomy.  Keeping the 
material confined proved to be difficult, however.  As a result the method gained little 
acceptance [46].
Other in situ forming nucleus replacements include silicon injected by Nachemson 
and Silicon Dacron injected into primate models by Urbaniak, bone resorption and 
aberrant bone formation in the latter study is believed to have led to the overall 
implantation of preformed devices [46].   Biodisc, by Cryolife is an injectable 
hydrogel that is protein based.  It was developed based on the company’s Bioglue 
product.  The material polymerizes over short time scales and has been proven to pass 
fatigue tests, though a 10% immediate loss in height occurred that slowly restored to 
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the original when the sample was subjected to 10 million cycles.  Further materials 
include the IDN (Injectable Disc Nucleus), by Spinewave, which is an injectable that 
is based on a silk-elastin copolymer, and DASCOR, by Disc Dynamics, Inc., a 
polyurethane that injects into a balloon and solidifies [47, 48].   Materials such as 
DASCOR have been proven to restore kinematics of the disc [49].  A thermoplastic 
nucleus replacement was also developed by Disc Augmentation Technology that 
injects and hardens at 66°C within the disc space [46].  
2.3.3.1 Historical Development
In 1934, Mixter and Barr identified the disc as the source of pain.  1950’s motion 
sparing technologies arose for replacing nucleus pulposus.  In 1955 David Cleveland 
injected methyl acrylic into the disc.  In 1959 Hamby and Glaser reported injecting 
the same material and were unsuccessful due to troubles with controlling the flow 
before the reaction had completed.  Spheres of cobalt chrome alloy were also 
implanted in a retroperitoneal approach after discectomy. 1962 Nachemson showed 
that spacers made of silicone rubber were incapable of withstanding physiologic 
loads, and in 1966 the Fernstrom stainless steel ball led to subsidence and 
extravazation [2].  
In a 1981 study, Edeland suggested the flow of fluid in and out of the disc tissue 
could be the source of their viscoelastic response under biomechanical loading [46]. 
The resulting fluid nature of the disc led to the selection of hydrogels.  The use of 
synthetic hydrogels in the field of nucleus replacement is intended by researchers to 
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mimic the behavior of soft tissue and such gels been in development since the late 
1980’s.  Hydrogel implants have been designed with the intention of either not 
swelling (remaining constrained to a fixed volume), or swelling, in order to 
completely fill the nuclear cavity.  Early work involving hydrogels include a device 
designed by Ray in 1988, as an injectable in situ forming gel that swells with the disc
[50].  Hydrogels’ ability to swell as they imbibe water as well as their ability to 
contract and deform may result in a reherniation through the defect in the annulus 
created when the implant is delivered.  This defect can be considered to be the 
direction of least resistance in a disc with an otherwise competent annulus [27].  The 
design of Ray was later adapted for this reason to encase the gel within a mesh for 
manufacturability (see Figure 2.8).  The resulting product from this effort was entitled 
the PDN (Prosthetic Disc Nucleus). 
Indications for the PDN did not include greater than Grade I spondylolisthesis, an 
incompetent annulus, low disc height (<5mm) or symptomatic degenerated or 
fractured facets [28].   These indications were restricted to degenerative disc disease 
with back pain (leg pain may or may not have been present since discectomy is 
capable of relieving leg pain, but often not back pain).  Low disc heights are not 
indicated because the device requires a competent annulus placed in tension [51].  
Concerns with implanting a preformed device such as the PDN include difficulties 
with creation of a cavity that matches the size and shape of the device.  Implantation 
also potentially requires a larger annulotomy [2].  Methods used for decreasing the 
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size of the annulotomy include, in addition to implantation of a swellable implant, the 
incorporation of two separate units.   An anterior tapered unit and a posterior 
rectangular unit were both implanted.  The anterior unit is delivered first, and the 
posterior unit is delivered second.  Both units are sutured together once in position 
[51].
PDN was further shown in a cadaveric study to restore mobility of a 5-6 gram 
denucleated disc.  Eysel evaluated PDN in 11 cadaveric functional spinal units.  A 38-
100% increase in mobility for the denucleated specimen was restored to intact state 
with no statistically significant difference [41].  Biomechanics testing for the device 
withstood up to 50 million cycles and maintained function of the implant, including 
disc height and viscoelasticity (loads were 200N and 800N).  Testing was performed 
for intact discs, as well as the 5-6 gram denucleated discs with and without PDN 
implantation.  Implantation proved stabilization was equivalent to pre-nucleotomy 
[2].
The first PDN clinical trials were conducted in 1996 with two implanted PDN 
devices.  Early clinical studies were effective, however trials from ‘97-‘98 showed a 
38% migration rate.  Migration was mitigated via revisions to surgical procedure and 
device shape [51].  A 10% reoperation rate was reported for the device due to 
migration [14].  
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Hypan was chosen as the swellable hydrogel.  The grade was switched during phase 
II trials (’97-98) to one that absorbs a greater amount of water, in order to provide a 
softer device, to avoid concerns of subsidence through the cartilaginous endplate that 
separates the disc from the vertebrae [51].  Hypan is a polyacrylonitrile based 
hydrogel copolymer that has seen other uses for implantation, in particular as a 
therapeutic bulking agent for the bladder [52].  A proprietary hydrolyzed 
polyacrylonitrile has been similarly used by Replication Medical in their NeuDisc 
nucleus replacement, where a dehydrated disc is inserted into the denucleated cavity 
and allowed to swell axially in order to restore disc height [27].  Replication has also 
marketed Gelstix™, a nucleus augmentation device, where a rod of hydrolyzed 
polyacrylonitrile is inserted into the disc and allowed to swell, as well as Gelfix™, a 
hydrolyzed polyacrylonitrile interspinous spacer.
By 2002, 480 implantations of PDN had been performed [46].  Between March and 
December 2002, a second study was performed with a single unit. In this second 
study, a range of levels in the lumbar of 45 patients were implanted with the device 
(26 men / 19 women: ranging 33-47yrs; average age of 35.6yrs).  Symptoms had 
lasted on average 12 months prior to surgery.  Disc gained 19.7% in height in 
comparison to the height before surgery.  Disc height was measured on X-rays.  
Results from the follow-up showed a statistically significant improvement in every 
measurement, over the preoperative state. 26/30 patients reported much improvement 
and 4/30 reported little improvement.  3 patients had back pain recurrence [28].  
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No migration was reported in the study, but four had markers not on a straight line 
with the disc.  No pain was reported in these patients and no measures were taken to 
correct this orientation.  Disc height increased to 10.3 over 8.6 on average 
preoperatively (19.7%).  Improvements in pain, leg pain in particular.  51 patients 
implanted with the PDN were followed for 4 years.  Initial success in these patients 
was reported at 91% at 3 months post-implantation. Failures within the trial are 
attributed to inappropriate patient selection, failure to remove all herniated nucleus in 
order to implant, and strenuous activity by patients soon after the procedure.  
Oswestry scores for the 51 patients decreased from 52 to 8.3 % after the 4 year 
period.  Mean disc height increased from 8.7 to 10.5mm over this period as well.  
Modification of the technique included rotation of the device 90° into a transverse 
position to avoid protrusion into the spinal canal [28].  
In addition to the standard posterior approach for implantation, a new surgical 
approach was introduced.  The ALPA, or Anterior Lateral transPsoatic Approach 
developed by Dr. Rudolph Bertagnoli allows the disc to be accessed from the side by 
way of the peritoneum, through the psoas muscle [51].  This approach allows the 
device to be inserted without the rotation required using the posterior approach.  In a 
clinical study by Schonmayr et al (10 patients) eight of ten of the procedures yielded 
results considered excellent.  Migration was observed in three patients, with one 
reoperation [2].  
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Polyurethane has been considered for use as a nucleus replacement by Fassio and 
Ginestie, Edeland, Froening, and Schulmann.  Polyurethane was chosen based on its 
mechanical properties, in particular compressive and tensile strength, as well as 
elongation at break.  The glass transition was identified to be at 1.1°C and 
degradation at 100°C.  Catalysts were chosen to minimize the exotherm produced 
from polymerization, as well as the rate of polymerization [53]  DASCOR, an implant 
by Disc Dynamics, Inc was an in situ forming polyurethane nucleus replacement 
designed to cure within a polyurethane bag.       
2.4 Poly(vinyl alcohol)
Poly(vinyl alcohol) (PVA) is a aliphatic polymer hydrocarbon chain with one 
hydroxyl per repeat unit (see Figure 2.9).  PVA is used as an emulsifier, as well as in 
the stabilization of colloid suspensions.  The material is used in water soluble 
coatings, textile sizing, and as an adhesive.  It is also spun into fibers [6, 54].  It is of 
particular interest as an implantable biomaterial due to its biocompatibility .
The hydroxyl moieties on poly(vinyl alcohol) interact via hydrogen bonding.  
Hydrogen bonding is a strong dipole to dipole interaction mechanism where hydrogen 
is attracted to non-bonding electrons in adjacent chemical structures.  This 
mechanism, though a strong form of interaction, is weaker than typical bonds, with 
20kJ/mol required to break a hydrogen bond, in contrast to approximately 400kJ/mol 
required to break an O-H bond. Hydrogen bonding has an effect on intermolecular 
interactions, producing substantial increases in boiling points of lower molecular 
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weight substances, and interactions between molecules which increase the apparent 
viscosity of hydrophilic materials when in an aqueous or polar medium [55].  
Hydrogen bonding is observed to occur between PVA and water, as well as between 
PVA chains or within the same chain. 
The water solubility of the polymer increases with percentage of hydroxyl units.  The 
solubility of the polymer reaches a maximum at 88% hydrolysis, beyond which point 
the interchain interactions take over, decreasing the solubility, requiring heating 
above 85°C to dissolve the material.  Due to the intermolecular hydrogen bonding of 
PVA, the crystalline melting point is high.  Fully hydrolyzed grades have melting 
temperatures above 230°C.  Further, the material can not be easily directly melted 
without significant degradation.  Processing of the polymer must therefore be 
performed in the solution state, or via plasticization [54]. 
Due to the presence of a keto-tautomer in the vinyl alcohol molecule, the majority of 
synthesis of the polymer is carried out indirectly through the initial production of 
polyvinyl acetate (PVAc) [54, 56], which is then hydrolyzed, as acetate groups are 
replaced with the hydroxyl by treating with an aqueous acid or alkali in alcohol 
solution, however due to resulting impurities, the method has been adapted to 
alcoholysis of polyvinyl acetate in the presence of sodium methoxide.  The 
conversion of the polymer is typically carried out in the solution or suspension state.  
The resulting gel from the process is chopped up and the reaction is stopped by the 
addition of acetic acid.  The remaining solid material is washed and dried.  PVA has 
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little branching.  Much of the branching in PVAc is cleaved off in the hydrolysis 
reaction [54].  The majority of polyvinyl alcohol in bulk grades is produced via the 
PVAc method and is largely atactic with 52-54% syndiotactic dyads [56].  PVA with 
a greater concentration of syndiotactic material has also been produced via poly(vinyl 
pivalate). 
Control over the portion of syndiotactic dyads is desirable, since hydrogen bonding is 
believed to be increased with greater percentage of syndiotactic material.  Increases in 
hydrogen bonding in PVA typically result in increased solution viscosity and gel 
mechanical properties.  Further, crystallization is believed to incorporate mostly 
syndiotactic dyads, in particular during the freeze-thaw physical crosslinking process.  
Despite this understanding, little has been reported on the complex rheological 
solution behavior of PVA [56]. 
Grades of polyvinyl alcohol are described based on their degree of hydrolysis, which 
is the percentage conversion of the acetate to hydroxyl groups.  The presence of 
hydroxyl groups increases the ability of the PVA to associate, via hydrogen bonding, 
with water, as well as with itself, often forming crystalline regions (see Figure 2.10).  
Crystallites are useful in distributing applied mechanical stress on the PVA network 
[57].  PVA has been shown to have good mechanical strength and elasticity, which 
make it suitable for the application of a load bearing tissue replacement [58].   Degree 
of crystallinity via infrared spectroscopy of PVA networks annealed at varying 
temperatures has been reported in pre- and post-swelling states by Peppas [59].  
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Crystallites forming in PVA are of the fringed micelle variety.  The formation of full 
crystalline spherulites is not typically observed.  The formation of crystals also 
depends on crosslink density.  Densely crosslinked polymers with a small molecular 
weight between crosslinks (Mc) will not crystallize [57].  Orientation of PVA has 
been evaluated using birefringence, and degrees of crystallinity are reported using 
calorimetric methods as well as density upon immersion [60].
The rheological responses of PVA in DMSO solution have been studied by Lee et al.  
In the study, thermal and shear histories were noted to be kept constant for prepared 
samples, via developing a standard dissolution technique. Samples were analyzed 
using 50mm sized parallel plates and a 1mm gap.  Tests were performed at 30°C.  
Samples were fully relaxed for 20 minutes prior to testing.  Specific and complex 
viscosity across a range of frequencies was reported, as well as the dynamic 
mechanical properties of storage and loss modulus.  The test was not performed 
across a range of temperatures, however, so the temperature dependent gelation 
behavior was not reported.  Instead, the relation of PVA concentration to solution 
properties was described.  It was determined that molecular weight had less of an 
effect on solution characteristics than the concentration, which suggested that polar 
effects from the hydrogen bonding of the hydroxyls played a significant role in 
solution viscosity [56].  
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2.5 PVA Hydrogels 
The fact that PVA sets to a gel upon standing is well known [6].  The resultant gel is 
tacky and of low modulus, however [61].  Typically, high water content results in 
poor mechanical properties for PVA gels and higher mechanical strengths limit gel
water content [61].  
Considering nucleus tissue is the source of hydration in the intervertebral disc, it is 
believed by many that a tissue replacement should similarly be hydrophilic.  
Polyvinyl alcohol hydrogels are commonly chosen for nucleus pulposus implants for 
their biocompatibility, as well as their ability to retain water [3].  Hydrophilic 
materials are currently being investigated as a way to maintain the swelling pressure 
within the disc through the retention of water.  Hydrogels have multiple states of 
water that are bound to different extents to the polymer network.  The most polar 
hydrophilic groups bind water the tightest and this state is described as primary bound 
water.  Secondary bound water is defined as the remaining water that interacts with 
hydrophobic groups as the molecule is swollen by the primary type “total bound 
water” is the sum of the two.  An understanding of water states is useful as it relates 
to the permeation of nutrients and cells in and out of an implanted gel [62].
Polyvinylalcohol hydrogels may be crosslinked by a variety of methods.  Many are 
prepared via chemical methods using a polyfunctional reagent that forms linkages 
between portions of adjacent polymer chains.  An example of this reaction is the use 
of glutaraldehyde, a bifunctional aldehyde that reacts with hydroxyl groups on PVA 
36
[63].  N-hydroxysuccinimide (NHS) esters form ester linkages through reaction with 
hydroxyls, though the ester bonds formed can be subject to hydrolysis in aqueous 
solution [64].  Boric acid and Congo red have also been used as chemical 
crosslinkers. 
Radiation is another method, where electron beam, ultra-violet light or gamma 
irradiation are used to create chemical linkages [57]  Irradiation below the Tg of the 
polymer has shown to result in degradation, where radical pairs are incapable of 
coupling [65].  In contrast, mobility of the polymer above Tg allows for crosslink 
formation upon irradiation.  The nature of the PVA solution is viewed to be 
analogous to the above-Tg state, with respect to crosslink formation [57].
Methods exploiting the network forming capabilities of the PVA gels in order to form 
a physically crosslinked network have been similarly developed.  Particular benefits 
to the formation of a network via physical crosslinks, as opposed to chemical, is the 
absence of toxic materials that could potentially leach from the gel [58].   As a result 
of this technique, the formation of crystallites provides crosslinks for the formation of 
a three dimensional network.  One common example of physical crosslinking subjects 
a PVA solution to successive freeze-thaw cycles.  Relatively dilute solutions of PVA 
can form into elastic constructs, using this technique.  
Crystallization in PVA hydrogels plays a large role in network formation for physical 
crosslinking [66].  It has been suggested that crystallization forms the basis of the 
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freeze-thawed network.  There is some debate over the exact process of this method 
of crosslinking, however it has been hypothesized that freezing water forces a phase 
separation of the PVA into domains that crystallize [67].
A semi-hydrated preformed poly(vinyl alcohol) implant (“Aquarelle”) was developed 
by Stryker.  The implant was 80% water.  The device was capable of being injected 
via a 4-5 mm tapered cannula through a disc having a small annulotomy.  The implant 
was delivered via a semi-open access technique, using a pressurized trocar [3, 17, 47].  
A preclinical trial reported extrusion in baboons.  The defect in the annulus resulting 
from access was further believed to accelerate disc degeneration, since accelerated 
degeneration was observed for the control group which received discectomy alone.  It 
was further believed as a result of this outcome that defect size must be decreased in 
order to reduce this consequence [14].   
In a related study by Allen, baboons were implanted with a PVA implant via an 
anterior approach that resulted in a 33% rate of herniation.  The implant consisted of 
98.5% hydrolyzed PVA which was crosslinked via freeze-thawing.  The implant was 
confirmed to maintain disc height upon application of load in cadaver segments. 
Implants were terminally sterilized using gamma irradiation.  Implantation followed 
denucleation using rongeurs. As a result, the implantation technique was modified to 
anterolateral, which still resulted in 20% rate of herniation.  Four of the six extrusions 
were in the posterior direction, with two in the spinal canal extradurally or 
intradurally.   Implants were well tolerated over the 24 month implantation, in 
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particular, extruded implants into both the soft tissue and the spinal canal were 
similarly well tolerated.  Implants further showed no signs of local or systemic 
toxicity.  As a result of histological analysis, tissues in animals having damaged 
implants displayed an inflammatory response. Particles from broken implants were 
encapsulated via a mechanism similar to a foreign body response.  Hyperplasia was 
observed via microscopy in the lymph nodes of three test specimens and one control, 
however no PVA particles could be found local to the site of analysis. Endplate 
damage was reported as a result of the study despite efforts to maintain the integrity 
of endplates during denucleation.  Harvested implants were observed to have 
flattened in the superior-to-inferior direction, which was expected since implants 
were reported to be intentionally designed to contour to the cavity, as well as to swell 
post-implantation.  The baboon model was also noted to have a higher intradiscal 
pressure than humans which would result in lower equilibrium water content upon 
swelling after implantation [23].
Viscosity was found to increase significantly with time.  In a study by Briscoe, 15% 
gels were measured for viscosity at t=0 and after 20 days.  When solution 
concentration was increased from 10-15%, the relationship of apparent viscosity with 
respect to time increased.  Greater concentrations produced greater increases in 
apparent viscosity over time.  Shear thinning behavior also became more pronounced 
at greater lengths of time, for concentrated solutions [6].  It has similarly been shown
that this time-dependent gelation is not observed for degree of hydrolysis of 88% or 
lower.  This is explained that the relative affinity for the polymer to bind tightly to 
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itself is disrupted by the smaller number of hydroxyls to bind, along the chain.  
Apparent viscosity is similarly decreased with decreased hydrolysis.  There is a 
corresponding increase in viscosity for very low degrees of hydrolysis, however, due 
to a decrease in polymer/solvent interaction resulting from an increase in the acetate 
group concentration[6].
  
Studies similarly exist, exploring the suitability of the mechanical properties of 
freeze-thawed PVA for use as tissue replacements.  In addition to nucleus 
replacement, the replacement of diseased or damaged cartilage in joints via 
implantation of PVA hydrogels in freeze thawed form has been considered [68].   
2.6 Poly(ethylene glycol) 
Polyethylene glycol (PEG) is described as a linear polyether because of its structure, 
which contains oxygen in its carbon backbone (see Figure 2.11).  Typically molecular 
weights above 20kDa are described as polyethylene oxide, however there is little 
difference and the terms are often used interchangeably.  
It has  been shown by Fabula that the addition of a small amount of polyethylene 
oxide to water results in a friction reduction that reduces the pressure drop at a 
specified flow rate to as low as one fourth [69].  Typical melting temperatures for 
moderate molecular weight (10-35kDa) commercially available PEG are in the range
of 60-70°C, with lower molecular weight material (0.4kDa) being in liquid form at 
room temperature.   PEG is known to crystallize readily forming spherulites [70].
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PEG binds to two or three water molecules for each ethylene oxide repeat unit in its 
structure.   The viscosity in the solution state is believed to be related not only to the 
molecular weight, but to the degree of hydrogen bonding.  The viscosity of the 
solution has been shown to decrease as temperature or pressure increases, as well as 
with the presence of electrolytes [6].  The presence of electrolytes has been shown 
also to reduce the solvent quality for PEG and other hydrogen bonded polymers, such 
as PVA.  Unlike PEG, however, PVA has strong interchain hydrogen bonding which 
affects solution rheology.
   
It is believed that the flexible chain on the PEG molecule as well as its ability to bind 
water molecules causes it to swell to 5-10 times larger than a soluble protein of 
comparable molecular weight.   PEG also acts by the same mechanism to exclude 
cells and proteins from surfaces.   Protein absorption has been decreased through the 
incorporation of PEO onto quartz surfaces in a study by Gregonis et al. [71, 72].  The 
increased hydrophilicity of PEO has also led to applications for interface/surface 
coatings.  
2.7 Polymer Solution Thermodynamics
A representation of the miscibility of polymer systems has been prepared by Flory 
and Huggins. The resulting expression describes the free energy of mixing of a 
system as it relates to the entropy and enthalpy [73]:
ΔGm = RT(n1lnφ1+n2lnφ2+n1φ2χ12)
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R: gas constant;
T: absolute temperature (°K);
φ : volume fraction;
n: # of moles; 
χ: Flory Chi parameter.
   
A value of χ of zero indicates miscibility in the system and a value of χ > 0.5 
indicates phase separation.  The equation described above is prepared for a single 
polymer (subscript “1”) in a single solvent (subscript “2”). The equation has been 
evaluated for greater than binary systems by adding greater numbers of terms for each 
component.  The Chi parameter must be evaluated for the interactions of the polymers 
with each other and the solvent. 
It should be noted that for the production of a phase diagram that %v/v yields the 
volume fraction term necessary for evaluation of the χ term.  In contrast, evaluation 
using %w/w is useful for establishing the compositional space for formulation. 
2.8 Hydrogel Swelling Thermodynamics
A number of theoretical models exist for predicting swelling properties in hydrogels 
for physiologic environments.  Current models lack application to the in vivo 
environment due to the deviation from ideality for the case of polymer networks in 
electrolyte solutions [74].  A reasonable approximation, however is the Flory-Rehner 
analysis, where gel networks of crosslinked polymers are considered, consisting of a 
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Gaussian distribution of polymer chain lengths.  The spontaneous process of swelling 
becomes favored thermodynamically when the polymer network is contacted by 
solvent. The decrease in free energy of mixing resulting from mixing of polymer and 
solvent is balanced by the elastic energy of the chains. A retractive force resulting 
from the crosslinks of the network is created to balance the pressure generated as a 
result of the swelling of the system.  A balance of the two forces describes swelling 
equilibrium.  The combination of the rubber elasticity theory and mixing 
thermodynamics generate the following equation [65] for a swollen system 
crosslinked in the absence of solvent:
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 : specific volume of the amorphous bulk polymer;
n
M : number average molecular weight of the polymer; and
χ1: Flory polymer-solvent interaction parameter.
The expression was adapted for crosslinking of a polymer in the solution state.  The 
r,2
  term was introduced as the volume fraction after crosslinking.  The equation is as 
follows[65]: 
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Crosslinking density is important since it has an effect on mechanical properties.
Crosslink density (ρ) is inversely related to molecular weight between crosslinks (Mc) 
by the following relation [65]:
ρ  = 1/υMc
where υ is the specific volume of the polymer.  Network mesh size  is the distance 
between crosslinks.  Crosslinking and ionic strength of the swelling medium will 
affect equilibrium swelling.  Swelling has been evaluated using the results from 
tensile experiments [65].
Mc, or the molecular weight between crosslinks can be evaluated through equilibrium 
swelling experiments, since mesh size is related inversely to Q (equilibrium swelling 
ratio):
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Characteristic correlation length, or average distance between consecutive crosslinks
can be determined from Mc:
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2.9 Phase Behavior of PVA/PEG
Ethylene glycol has been described as a solvent for PVA [54].  Increasing molecular 
weight leads to an incompatibility between the two polymers.  According to early 
research, over a given concentration range for PVA/PEG aqueous solutions, there is a 
phase separation that occurs, yielding a concentrated aqueous PVA phase and a dilute 
aqueous phase of PEG.  The first evidence of the study of this phase separation was in 
1968, when Toyoshima et al reported the binodal for low degree of hydrolysis PVA 
(88%) and 4kDa PEG.  In the case of this study, a highly hydrolyzed material was not 
found to produce a phase separation [75, 76].  Further, more comprehensive work was 
done by Inamura et al in the 80’s, including greater degrees of hydrolysis as well as a 
variety of molecular weights of both polymer components.  
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The ternary diagram is related to a polymer-solvent-nonsolvent system in Tompa.et al 
(see Figure 2.12).  Three component systems for incompatible materials have been 
described by Flory in detail [73].  Particular attention was paid to 
polymer/solvent/non-solvent systems.  Inamura states that for high molecular weight 
PVA, the system is best approximated in this manner, due to the increased 
incompatibility with PEG [76].
The ternary diagram for an incompatible system such as will be described is 
constructed of a binodal curved line representing the phase boundary separating the 
immiscible region (having two or greater phases) from the miscible (one-phase) 
region.  Typical representations of ternary systems consist of a triangle with each 
vertex corresponding to 100% of one of three components.  The composition of three-
component systems is defined in the space by orthogonal distance to each of the three 
vertices.  Formulations prepared in the two-phase space separate to two different 
compositions on either side of the parabolic binodal curve.  For example, a 
composition prepared that would fall in the two-phase region would separate into a 
lower layer of one composition and an upper layer of another composition.  These 
two layers will have composition points on the binodal curve, and the line connecting 
these two points is called a “tie line”.   Tie lines yield information about the behavior 
of a system.
Research on PVA/PEG phase diagrams by Inamura came primarily in two separate 
papers, the first (1984) discusses the phase separation that occurs for dilute 
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formulations (less than ~30% total polymer) [76].  These papers describe the 
formation of the concentrated PVA-rich phase and the dilute PEG-rich phase [76].  
Inamura prepares a ternary diagram for this small region of concentrations.  PEG is 
added volumetrically in a systematic manner and the concentrations where turbidity 
occurs in the solution is determined to be the position of the onset of phase 
separation, and the subsequent location of the binodal.  Phase separation data is 
shown for systems with PVA = 93kDa and PEG = 7.2-668kDa.  The binodal for this 
system is defined and the curves are shown to move upward on the ternary diagram 
with PEG molecular weight  (see Figure 2.13a). A wide range of molecular weights 
was also chosen for this study for both polymers (PVA: 37-730kDa; & PEG: 7.2-
668KDa), and a similar behavior is observed with respect to PEG molecular weight 
(see Figure 2.13b).   Findings from this research have shown that the binodal for each 
system moved upward, producing a much greater region of phase separation, as the 
molecular weight of either PEG or PVA increased.  On a ternary diagram, this is 
represented by the apex of the binodal moving closer to the corner representing 100% 
H2O.  Higher molecular weights produced phase separation at increasingly more 
dilute solutions.  This agrees with the thermodynamic understanding that a larger 
molecule will be less entropically favored to mix.   As PEG molecular weight 
increased, the binodal inclined toward the H2O - PVA axis up to 2000kDa, after 
which the binodal moved toward the PVA - PEG axis.   It was also observed that low 
molecular weights of PEG (<0.6kDa) did not produce a phase separation.  
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The Flory χ parameter can be expected to vary based on the system.  For ternary 
systems of polymers with the same molecular weight, χ12  is greater than χ13 when 
there is an incline toward the axis of components 1 and 2.  In other words, an incline 
toward the PVA-water axis for a PVA/PEG system of the same molecular weight 
would mean the formation of a dilute PEG phase and concentrated PVA phase. 
Through this observation it was determined by Inamura that water is a better solvent 
for PEG than PVA in the PVA/PEG/H2O system.  The binodal curve can also be 
expected to be symmetric and tie lines can be expected to be approximately parallel to 
the polymer/polymer axis for polymers of the same molecular weight [76].
More concentrated solutions of PVA were explored in the later Inamura publication
(Figure 2.14).  Concentration approached 50% for PVA and PEG for this study, 
however PVA molecular weight in this case was low (38kDa), in comparison to the 
molecular weights to be considered for a load bearing material.   A ternary diagram 
and binodal for the PVA/PEG/H2O system were also determined in this study.    This 
work stated a molecular repulsion for the two polymers as reason for the phase 
separation.
Work by Lim has  been performed on the plasticization of BaTiO3 sheets with 
poly(vinyl butyral) as the binding agent.  It was found that the incorporation of PEG 
resulted in a decreased viscosity and plasticization behavior, as hydrogen bonding 
decreased.  Hydroxyl peaks in FTIR were shown to decrease with the addition of 
PEG [5]. 
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Recent work suggests that a specific phenomenon has been identified for the phase 
separation of similar incompatible systems.  For instance, it has been observed that 
the incorporation of an electrolyte in solution, has the effect of decreasing the 
viscosity of a solution, through interference of hydrogen bonding.  Similarly, the 
presence of the electrolyte is capable of reducing the interaction between PVA chains 
and the solvent [6], while solute (electrolyte) and solvent (water) interactions are 
increased.  The resulting effect is a temperature-related jump in solution viscosity that 
occurs at a critical concentration of salt in solution.  
Incorporation of low degree of hydrolysis material has shown to produce solution 
effects where upon incorporation of lower degree hydrolysis PVA, the PVA becomes 
increasingly more likely to phase separate at higher temperatures.  The reason for this 
effect is explained as the incorporation of greater amounts of hydrophobic material in 
the low degree of hydrolysis PVA.  In other words, since low degree of hydrolysis 
PVA has such a large amount of acetate groups remaining, the hydrophobic character 
of these groups results in a disruption of the behavior in solution. The Viscosity 
measurements vs. temperature show a transition for low degree of hydrolysis PVA 
(see Figure 2.15).  Observed as a result of this solubility change is a transition in 
viscosity, where PVA no longer hydrogen bonds with the solution to the same extent, 
above a given temperature.  The resulting change in hydrogen bonding properties 
reduces the apparent viscosity of the solution.  
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Similarly, when NaCl solution is added in varying amounts there is a similar viscosity 
reduction behavior, as greater amounts of NaCl reduce the hydrogen bonding between 
polymer and solvent, this reducing the apparent viscosity.  In the study by Briscoe, 
poly(vinyl alcohol) was observed to precipitate out at temperatures above the 
transition temperature, suggesting that the affinity for water had been decreased.  Low 
degrees of hydrolysis are shown to result in a high temperature phase separation that 
results in a viscosity decrease.  See Figure 2.15.  The phenomenon observed by 
Briscoe is an interference in hydrogen bonding association of PVA with water that 
results in a solubility transition that is manifested in a viscosity transition.
Theta-gels have been proposed by Ruberti et al [77], where through manipulation of 
the solubility characteristics of PVA (via reduction of solvent quality and the 
inclusion of a theta solvent), a physically associated gel network is formed.  In 
Ruberti, the theta solvent is thought to force PVA chains in solution into concentrated 
domains that resist dissolution.  Further, Ruberti describes the addition of a theta 
solvent to PVA as resulting in a spinodal decomposition, which occurs in unstable 
supersaturated solutions, where spontaneous clustering is thermodynamically favored.  
The combination of solutions such as NaCl/water, and methanol/water with PVA, are 
also described to create the theta gelled state.  Ruberti et al states without citing a 
particular theory, that crystalline physical crosslinks are formed, in contrast to the 
random associations of normal concentrated aqueous PVA gels.  Calorimetry 
experiments later in this thesis will be performed to probe for ordered crystalline 
structure, such as that shown by a physically crosslinked freeze-thawed gel.  Oral et al 
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describes low molecular weight PEG (0.4kDa) incorporated into PVA gels, which has 
been shown by Inamura to not produce the supernatant phase [76, 78].  Potential 
nucleus replacement technologies are described using similar systems [77].  Work by 
Choi et al further describes the creep behavior of such gels as it relates to equilibrium 
water content.  Creep is seen to decrease with the dehydration of the theta-gels.  
Dehydration via isopropyl alcohol is shown to reduce equilibrium water content, and 
increase creep resistance the most.
Though similar, the differences and improvements of the system of this thesis are 
described throughout the following pages.  To be specific, the system described is a 
polymer blend with higher molecular weight PEG or PEO which exhibits an
enhanced gelation transition.  The incorporation of the PEG into the network
produces a reduced interaction between PVA and water as described by Lim [5]
which in turn results in the viscosity transition as described in Briscoe [6].  The 
production of the viscosity transition occurs spontaneously with interacting polymer 
functional groups within the network (i.e. without the inclusion of a theta solvent) 
that produce the high temperature vinyl alcohol/water interference that is the source 
of the high temperature plasticization. The incorporation of higher molecular weight 
PEG into the PVA network results in a viscosity transition, in the manner observed at 
high temperatures by Briscoe et al, as hydrogen bonding between PVA and water is 
disrupted resulting in a decrease in apparent viscosity.  This viscosity decrease allows 
for flowability at increased temperatures where concentration and network effects 
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would otherwise prohibit flow.   This high temperature phenomenon is in contrast to a 
low temperature spinodal decomposition suggested in Ruberti et al [6, 77].
PEG has also been used in conjunction with PVA in order to decrease protein 
absorption and cell deposition to reduce thrombogenicity in cardiovascular 
biomaterials [79].  PEG was oxidized to yield aldehyde groups.  It was also 
functionalized with isocyanate end groups, both mechanisms with the intention of 
reacting PEG to PVA [80]. 
In 1995, Lozinsky studied the effects of polyols on the structure and properties of 
cryogels.  Polyols have been known to be cryoprotectants, that is, to depress freezing 
temperatures of aqueous solutions.  Polyols also are used to reduce ice crystal size, 
and have been shown to inhibit crystallization enough to allow for glass formation of 
water.  Polyethylene glycol was incorporated into gels (at 400 and 1000 molecular 
weight) and was shown to increase strength and thermostability of PVA cryogels.  
Lozinsky mentions formation of gels by pooring the mixed solvent quality.  Gels 
produced using this technique of reducing the quality of the solvent are then freeze-
thawed, resulting in increased mechanical properties, and have been suggested as a 
means for fabrication of soft contact lenses [61]. 
In recent years, PVA and PEG blend gels have been developed that are physically 
crosslinked via a freeze-thaw process in order to produce a double network, which 
results in high mechanical strength [66].  Mechanical strength has been found to be a 
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factor of composition for these gels.  Both fracture strength and strain have been 
shown to vary with crosslinking for poly(2-acrylamido-2-methyl-1-propane-sulfonic 
acid / polyacrylamide gels [81].  It has further been shown that dynamic storage 
modulus increases with increasing amount of PEG in the hydrogels, suggesting that 
the elastic nature of the gels is increased with PEG content, from 2 to 6 wt. %.  
A study in the journal of radiation research and radiation processing regarding the 
biocompatibility of PVA/PEO gels stated that blend hydrogels made up of these two 
components exhibited no acute general toxic effects on mice [82].
PVA/PEO gels have found use as adhesion barriers and wound dressings, due to their 
unique surface properties.  The use of the PVA/PEO hydrogels in wound dressings 
has a number of distinct advantages, including faster wound healing, as well as no 
sticking of material to the wound, and further, no material remains behind after the 
dressing is removed.  In a study by Yoshii et al., PVA was added to PEO hydrogel 
wound dressings crosslinked via electron beam in order to impart toughness to the 
material [83].  Also, a PVA/PVP/polyethylene oxide hydrogel burn and wound 
dressing under the name of Woundragel has been under development in Vietnam. 
Similar hydrogels have been evaluated for treatments of a variety of wound dressings 
for lesions due to leprosy in India.  A PVA agar PEG gel has been similarly 
developed in Bangladesh.  Other materials, such as plant starches have been used in 
combination with PVA in eastern countries, in order to keep production costs low.
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2.10 Biocompatibility
A. Hoffman [71] defines biocompatibility as success of the device in fulfilling it’s 
intended function.  Hoffman states that only complete devices and never just 
materials gain FDA “approval”.  Instead, bioreactions (reactions between materials 
and biological systems) are a simpler phenomena to understand than biocompatibility.  
Hoffman mentions that toxicology assays are commonly inappropriately referred to as 
an assessment of biocompatibility.  The tests are concerned with substances leaching 
from a material.  It is these leachables that will elicit a bioreaction in cells and tissues.  
For materials that do not leach substances, bioreactions are strongly affected by 
surface properties.  Other characteristics potentially affecting bioreactions include 
porosity, location of implant, hardness and shape.  Swelling character is also a 
consideration for hydrogels.  Bioreactions are predicted through the determinations of 
correlations that arise between material properties and the resultant bioreactions.  
Fluids with a given critical surface tension exhibit a minimum in biointeraction.  
Further, correlations between cell adhesion and surface energy have also been 
investigated in nonproteinaceous media.    It was further stated that correlations of 
bioreactions with material properties are rare.  Problems referenced were difficulties 
in assembling a large enough experimental population, as well as the complexities of 
the human biology and of the biomaterials themselves.  
PVA is known to be well tolerated as an implantable biomaterial [23] producing no 
systemic or local toxic effects. This material has been evaluated for implantation in 
physically crosslinked hydrogels, such as the Aquarelle and Hydrafil nucleus 
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replacements and is currently being evaluated as an embolic therapy where 
microspheres are implanted via a catheter (Biocure), in order to block blood flow to a 
tumor.
Polyethylene glycol is similarly widely used as a biomaterial, due to its inherent 
biocompatibility.  PEG has gained FDA approval for use in drug formulations [84], 
and intramuscular injectables [85].  The biocompatibility of the material is based on 
its nonimmunogenicity, nonantigenicity and protein rejection properties
.
Further, surfaces of materials have been coated with PEG for expressly improving 
their biocompatibility.   Nonionic PEO hydrogels and have been used in blood contact 
applications.  PEO surfaces have been described as less thrombogenic, which leads to 
less protein absorption.  Surface induced thrombosis and device failure is minimized 
by the incorporation of PEO onto surfaces [71].  Interactions between cells and 
macrophages, which are understood to a key element in the foreign body response, 
are determined by observing protein adhesion and morphology of cells, post-
implantation.  Protein resistance is an important aspect of biocompatibility.
Protein absorption is related to molecular weight in that the amount of protein 
absorption has been seen to be a strong function of molecular weight for low 
molecular weights (700-1900 Daltons) [86].  The reason is cited as that lower 
molecular weights are incapable of folding into a hydrated coil.  This coil excludes 
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higher molecular weight solutes from the surface.  These effects can be seen to level 
off at increasingly higher molecular weights.
Interactions at a biomaterial surface are considered to be of high importance.  
Materials are known to be modified with PEO in order to reduce surface-induced 
thrombosis.  The process resulting from initial exposure of a foreign substance to the 
blood, begins with protein absorption onto the surface, and then leads through a 
complicated series of steps before ultimate blood biocompatibility is determined.  The 
correlation between surface induced thrombosis and blood compatibility has not yet 
been established, however.  
For drug delivery using PEO functionalized heparin, as a result of the increasing 
hydrophilicity and dynamic motion of PEO, the adhesion of platelets and absorption 
may be decreased.  Spacers of PEO were used to immobilize heparin.  The PEO 
showed an increased bioactivity over a hydrophobic spacer.  PEO is indicated for 
drug delivery because of its unlimited solubility in water, high mobility in water due 
to its chain conformation, as well as an excluded volume that is large enough to repel 
cell and protein interactions [71].
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Figure 2.1 The spine, viewed laterally [7]
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Figure 2.2 An intact disc and states of nucleus pulposus prolapse [87]  
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Figure 2.3 Axial compressive loading of an intact intervertebral disc.  Pressure of 
nucleus tissue puts annular fibers in tension [8].
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Figure 2.4 Posterolateral thoracic discectomy procedure using rongeurs [88]
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Figure 2.5 Posterior Lumbar Interbody Fusion (PLIF) [89]
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Figure 2.6 Prodisc-L - Lumbar total disc replacement [90]
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Figure 2.7 Acroflex total disc [91]
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Figure 2.8 Prosthetic Disc Nucleus (PDN) [92]
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Figure 2.9 Poly(vinyl alcohol)
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Figure 2.10 Physically crosslinked network via crystallites [57]
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Figure 2.11 Poly(ethylene glycol)
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Figure 2.12 Above is shown ternary diagrams for solvent (S) / non-solvent (NS) / 
polymer (P) systems.  Tie lines are represented as well [93, 94].
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Figure 2.13 PVA/PEG ternary diagrams dilute formulations of  a) PVA= 93kDa 
/PEG = 72-668kDa (at left) and b) PVA= 37-730kDa /PEG =20kDa [76]
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Figure 2.14 PVA/PEG ternary diagram for 38kDa PVA and varying PEG molecular 
weight (0.6-594 kDa).  “a” shows no phase separation of low molecular weight PEG. 
“b-e” (depicted as ----) show increasing PEG molecular weight.  Phase separation line 
moves upward with PEG molecular weight [4].
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Figure 2.15 Viscosity vs. temperature transition at varying degrees of hydrolysis
from Briscoe.   represents the lowest degree of hydrolysis, which show the greatest 
transition;  represents the next lowest degree of hydrolysis (78%) and represents 
the highest (83%) [6].  
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CHAPTER 3: RESEARCH GOALS
The primary goal of this research is to prepare and characterize an injectable in situ 
forming nucleus replacement with adequate gelation and stability characteristics.  
Gels are designed in order to support biomechanical loads of the spine, as well as to 
withstand the physiologic osmotic environment of the intervertebral disc.  Systems 
are developed as blend hydrogels, lacking the presence of potentially toxic 
crosslinking agents. Poly(vinyl alcohol) will be blended with poly(ethylene imine), 
poly(vinyl pyrrolidone) and poly(ethylene glycol).  An understanding of the resulting 
systems due to the combination of the incompatible PVA and PEG components will 
be obtained via phase diagram.  An understanding of changes the gel might incur as a 
result of implantation of a given formulation must be known, such as the potential to 
imbibe water and lose stability.  Improvements over neat PVA hydrogels in setting 
characteristics are necessary, and the resulting temperature-dependent gelation profile 
will be evaluated in order to describe short-term setting and gelation characteristics of 
the systems.  
Specific Aim 1.  Prepare and characterize an injectable in-situ solidifying PVA-based 
hydrogel system.
Specific Aim 2.  Characterize PVA/PEG phase behavior
Specific Aim 3.  Characterize swelling and stability of the PVA/PEG system
Specific Aim 4.  Characterize gelation of the PVA/PEG system
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CHAPTER 4: SELECTION OF A MATERIAL SYSTEM
4.1 Introduction 
A range of systems was considered for combining polyvinyl alcohol with a material 
that will impart a quick forming nature. In the systems of interest, a supersaturated 
aqueous PVA solution was combined with a second component, either 
polyethyleneimine, polyethylene glycol, polyvinyl pyrrolidone, or polyvinyl alcohol 
of a lower molecular weight.  Molecular weights as well as component B content 
were varied.  Solutions of the materials were prepared at elevated temperatures and 
then allowed to cool to 37°C.  The percentages of components are given in Table 4.1.
4.2 Experimental 
PVA solutions were prepared by autoclaving a 28% w/w concentration aqueous 
solution in an autoclave at 121°C for 30 minutes.   Each of the four components 
described in Table 4.1 were then mixed into solution.  Control samples of 28% PVA 
(Mowiol 28-99) without addition of a Component B material were similarly prepared, 
for comparison.  The resulting gels were immediately loaded into Viceroy screw 
syringes (manufactured by Merit Medical Inc.) and injected into cylindrical molds via 
a trocar and allowed to cool to 37°C overnight.  Gels on the following day were 
removed from molds and observations of their physical and mechanical properties 
were recorded. 
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4.3 Results/Discussion
Qualitative observations were obtained for samples of blends (PVA/PVA, PVA/PVP, 
PVA/PEI, PVA/PEG) as listed in the experimental section.  Samples are compared 
below by being grouped by concentration of component B.  
In none of the samples from the set containing 5% of component B (PVA, PVP or 
PEI, with the exception of the PEG) was there a noticeable improvement in stiffness 
over the control.  Each sample bowed under its own weight when removed from the 
mold and could be shaped or deformed easily with handling.  Samples containing 5% 
PEG were malleable and deformed easily.  Modulus may have increased over the 
control but was not measured.
For samples containing 10% of PVA, as component B, none showed a dramatic 
improvement.  Slight improvement was observed with incorporation of 10% 9-10kDa 
PVA with low degree of hydrolysis as component B.  These preliminary results were 
later attributed to crystallization effects for lower molecular weight PVA, as 
described in the swelling and stability section of this thesis.  10% PVP samples 
exhibited a slight noticeable increase in stiffness with molecular weight. 10% PEI 
samples were of moderate stiffness.  PEG samples exhibited an increase in stiffness 
over other samples.  PEG samples also seemed to increase slightly in stiffness with 
molecular weight.  PEG samples appeared homogeneous   For 10% of the highest 
molecular weight PEG as component B, samples recovered well when compressed 
manually to ~50% of their original height.
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For the sample set with 20% 9-10kDa low degree of hydrolysis PVA as component 
B, gels had a relatively high modulus.  This was not observed for 13-23k (sample was 
soft).  31-50 had solidified a bit, but not as much as the 9-10 sample.  Results for low 
molecular weight material were later attributed to the same reason described 
previously for 10% 9-10kDa PVA samples
The remaining samples with 20% of component B were observed to have the
following properties. PVP samples showed an increased viscosity and were difficult 
to mold.  PEI samples at this concentration retained their shape.  Modulus was 
slightly higher.  PEG samples formed a rigid, high modulus gel with an expelled 
supernatant remaining in the mold.  The presence of supernatant accounted for the 
strange shape of the sample. 
Generalized observations for the sample set were as follows.  In general, modulus 
was observed to increase with molecular weight for each component B polymer type.  
Low molecular weight PVA was an exception.  The effects of low molecular weight 
PVA are better described in the swelling section of this thesis, as the physical 
properties of the gels are observed to change with incorporation of this component.  
Modulus increased with component B percentage for each polymer type, which was 
to be expected since polymer concentration was increasing and water content was 
decreasing.  PVP samples exhibited an increased modulus and injection viscosity at 
higher concentrations.  Further, at any given concentration of component B, PEG 
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samples showed the greatest stiffness.  For this reason, the most attention was paid to 
the PVA/PEG formulations.  Samples containing PEG were viewed to be the best 
candidates to meet the requirements that the material be biocompatible, injectable and 
capable of quickly gelling to an elastic solid.
Results varied for each of the systems evaluated.  Polyethyleneimine at higher 
concentrations produced samples that were physically difficult to tear apart, modulus 
increased for 9-10kDa PVA with lower degree of hydrolysis.  Not a large enough 
effect was observed for low molecular weight PVA.  
Compressive modulus data was obtained for PVP 40kDa samples.  Results indicated 
that modulus had increased significantly for test samples when compared to a control 
sample consisting of only 28% PVA 28-99 (see Figure 4.1).  Samples retained a tacky 
character, however.  Injection viscosity became too great for samples containing 
360kDa to be considered.
Observations of samples prepared in this initial study showed that samples containing 
PEG in lesser amounts (5-10% of total mass) produced a swollen hydrogel of 
noticeably higher modulus.  Adding a progressively larger amount of PEG (20% of 
total mass) to the PVA solution yielded samples that were considerably more rigid.   
A relatively large percentage of fluid also was observed to have expelled from gel
(See Figure 4.2).    It was determined that a gel with the appropriate elastic response 
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would likely be between the values of 10 & 20%.  As a next step, 15% samples were 
prepared to evaluate their properties.
In the process of preparing 15% samples, expelled supernatant was decanted and 
removed, thereby increasing the polymer content of the samples.  Solids needed to be 
autoclaved in order to restore a flowable state.
Compressive mechanical testing was also performed for PVA/PEG test cylinders 
made in similar molds.  Modulus at 15% strain was determined to be greater at 
shorter times for test samples, in comparison to formulations without PEG.  
Preliminary data yielded a mean compressive modulus of 74.8kPa at 30 minutes, 
which is above the data for PVP previously shown in Figure 4.1 (max. of 54kPa) 
which was taken at 18 hours.  PEG was chosen for its quick setting response as a 
result of these tests.
A portion of a PVA/PEG 15% sample had been freeze-dried and was analyzed using 
FTIR in Attenuated Total Reflectance mode.   The spectrogram obtained for the 
material indicated that PVA and PEG were present, however any understanding of 
network formation could not be obtained from the data.  It was suspected that 
interactions of the complex solution were creating a physical network, since heating 
solutions to high temperature would restore flow to solid material, suggesting a 
melting out of physical associations.
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The results of physical crosslinking will be explored, as part of this thesis, using 
differential scanning calorimetry, in order to search for evidence of crystalline 
physical crosslinking, as a result of the “melting out” that has been observed to result 
as the gels transition to a lower viscosity flowable state, as temperatures are elevated.  
The presence of crystalline physical crosslinking would be expected to be observable 
as an endotherm produced by melting crystallites, as has been observed for freeze-
thawed PVA gels.  Due to the resulting formation of freeze-thawed networks due to 
selective crystallization via phase separation as described previously (Section 2.5 
PVA Hydrogels [95]), it is understandable that the incorporation of another material 
(i.e. PEG) may result in the formation of dense PVA domains which are capable of 
crystallization.  The formation of crystallites is doubtful however, as the complex 
process occurring during freeze-thawing is not transferrable to the simple phase 
separation of the PVA/PEG system. 
4.4 Formulation Naming Method and Component Descriptions
Due to the large number of possible formulations that will be explored, for the 
purposes of this thesis percentage of components will be named using the following 
format:
FA-B/C
F indicating that it is a formulation.  A refers to a chronological numbering system 
describing percentages of each component, the percentages of each is described in 
Table 4.2.  The system being explored will primarily consist of the PVA/PEG/H2O 
gel, The terms B and C refer to the molecular weights (in kiloDaltons) of PVA and 
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PEG, respectively.  For example F1-145/10, would have the percentages in Table 4.2 
with 145kDa  PVA and 10kDa PEG.  99:1 polyvinyl pyrrolidone is added as a
stabilizing agent[96].  Barium sulfate is added to produce a gel that is visible under 
fluoroscopy, for the purposes of visualization upon implantation.  The percentage of 
barium sulfate will be set at 7% w/w where possible, since it is believed to be the 
lower limit of visualization for the implant.  Varying levels of phase separation and 
dehydration will produce gels with greater concentration of these dry components.  
The grade of PVP will be unchanged at 58kDa (Plasdone C-30, ISP Corp.), unless 
otherwise noted.  The barium sulfate used for all studies is manufactured by J.T. 
Baker (USP Grade, Cat#:1040).   All percentages used will be weight-per-weight 
(%w/w), unless otherwise noted.  Note that water is added by weight in these 
formulations.
4.5 Sample Preparation, Storage, Handling and Delivery Methods
The steps for preparation are shown in Figure 4.3.   It was observed, early on, that the 
hot PVA solutions mixed with PEG would maintain their flowability.  Early gels 
stored in the 75°C water bath would remain flowable until use.  Brief processing steps 
using the water bath maintained at 75°C were still employed for handling gel since 
higher temperatures were considered to be dangerous.  Concentrated PVA solutions 
were created in an autoclave (121°C/30min).  Once removed from the autoclave, 
solutions were allowed to cool slightly in the 75°C bath before use.  Barium Sulfate 
and PEG was added and mixed into the hot solution while the bottle was in the 
heating bath.  The bottle was allowed to cool to room temperature for three hours to 
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allow for supernatant to form.  Supernatant was decanted, the solution was autoclaved 
again to make it flowable.  After a final decant, the material was ready to be molded .  
The material was molded, while hot, into stainless steel cylinders, and the ends were 
fitted with rubber caps, forming flat-ended cylinders of 18mm diameter and 100mm 
length.  These cylinders were stored in resealable plastic bags at room temperature, 
filled with ~3ml of DI water to prevent drying until use.  In some cases, cylinders 
were sealed with ~3ml of water inside foil pouches.  Cylinders were inserted into a 
delivery gun capable of heating the gel and extruding it through a luer fitting at its 
aperture.  The luer fitting is capable of attaching to a cannula for delivery.  The gun 
operates via a trigger ratcheting mechanism to deliver heated gel through the cannula 
to the intended implantation site.     
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Table 4.1   Component Options for Material Systems
Component A 
(wt. %) Component B (wt. %)
PVA 28% 
Soln(145kDa) PVA(9-10k) PVA(13-23k) PVA(31-50k)
80 20 20 20
90 10 10 10
Set 1
95 5 5 5
PVA 28% 
Soln(145k) PVP(~10kDa) PVP(~40k) PVP(~360k)
80 20 20 20
90 10 10 10
Set 2
95 5 5 5
PVA 28% 
Soln(145k) PEG(~1k) PEG(~10k) PEG(~35k)
80 20 20 20
90 10 10 10
Set 3
95 5 5 5
PVA 28% 
Soln(145k) PEI(~10k) PEI(~60k)
80 20 20
90 10 10
Set 4
95 5 5
81
Table 4.2 Formulations
Formln # F1 F2 F3 F4 F5 F6
PVA 20.2% 9.1% 20.2% 22.4% 10.2% 20.2%
PVP 0.2% 0.1% 0.2% 0.2% 0.1% 0.2%
H2O 55.0% 55.0% 45.0% 38.8% 50.0% 50.0%
BaSO4 7.0% 7.0% 7.0% 7.8% 7.0% 7.0%
PEG 17.7% 27.5% 27.7% 30.7% 32.7% 22.7%
Notes:
+10% 
PEG
+10% 
PEG
+13% 
PEG
+15% 
PEG +5% PEG
-10% 
PVA
-10% 
H2O
+20% 
PVA
-10% 
PVA -5% H2O
-16% 
H2O -5% H2O
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Figure 4.1 Modulus data for poly(vinyl pyrrolidinone) / polyvinylalcohol gels 
at varying PVP content
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Figure 4.2 Resultant gel from a component B of 20% PEG was stiff and dehydrated.
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Figure 4.3 Sample preparation steps for PVA/PEG gels
Gelation                
(autoclave 30min/ 
121°C)
Add H2O, PVA & 
PVP to media bottle
Start
Add barium sulfate to 
bottle (75°C)
Add PEG to bottle
Discard supernatant 
phase
Gel isolation/decant at 
75°C
Mold gel phase / cool to 25°C
End
PVAaq solution 
formation              
(autoclave 30min/ 
121°C)
Mix/disperse BaSO4    
(autoclave 30min/ 
121°C)
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CHAPTER 5: PHASE BEHAVIOR AND COMPOSITION
5.1 Introduction 
A phase separation that occurs due to the incompatibility of these two polymers 
allows for products that could not be developed otherwise.  Concentrated PVA 
solutions are capable of being further concentrated past the point that would be 
directly processable.  For example, for certain concentrated formulations, without 
utilizing the phase separation technique via PEG addition to the PVA gel, there is not 
enough water in the formulation to solubilize the PVA granules.  The gel that is 
formed has a high setting viscosity due to the concentration, as well as a willingness 
to flow at high temperatures that is attributed to the incorporation of the PEG 
plasticizer.
   
When an attempt is made to produce the same final formulation of gel that results 
from the phase separation technique there was not enough water available to bring the 
PVA granules into solution.  The method chosen for homogeneously solubilizing 
PVA at these high concentrations is autoclaving at 121°C / 30 psi for 30 minutes 
while sealed in Pyrex media bottles.  Even under these aggressive conditions, when 
test formulations were attempted to be prepared directly they resulted in PVA that 
was not solubilized to a great extent.  In this case the production of the gel relies on 
the method used to produce the gel.  At this particular formulation, the production of 
a homogenous gel is not possible without dehydration of a more dilute gel because of 
the solubility limit of the PVA that is being used.  The gel that is produced is in a 
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supersaturated state as a result of the dehydration that occurs via the PEG addition 
stage.  The phase separation is useful, in part, because it allows one to produce 
hydrogels of an increased concentration, as supernatant removes water from the gel
(see Figure 5.1).  Phase separation has further been shown to occur in PVA/PEG 
systems at greater than 0.6kDa PEG, for these reasons systems will be limited to 
higher molecular weight PEG [76].  The following sections describe the means 
necessary for the definition of the allowable compositional space, as dictated by this 
phase separation mechanism.  A phase diagram is prepared for the range of 
concentrated formulations required for a load bearing hydrogel, such as that required 
for nucleus replacement.  Methods for separating the similar PVA and PEG polymers 
comprising the resultant concentrated samples in order to produce this phase diagram 
are also developed. 
5.2 Theory of the Phase Separation of Aqueous PVA/PEG 
As described earlier in this thesis, incompatibilities are known between PVA and 
PEG.  The incorporation of PEG into aqueous PVA solution results in a phase 
separation which produces a polymer-rich gel phase and a dilute water-rich 
supernatant phase [76].    PEG is well known as a plasticizer for polymers [85], in
particular for PVA [5].  A reduction in hydrogen-bonding in vinyl alcohol units was 
observed by Lim through the use of PEG.  This reduction in H-bonding was identified 
using FT-IR.   Lim further found that molecular weight of PEG affected plasticization 
effect.  In an earlier paper [5], Lim describes PEG affecting crystallite formation in 
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PVA films.  The mechanism that is suggested is the introduction of defects into the 
PVA crystal lattice.  
PVA/PEG phase diagrams prepared by Inamura use a stepwise addition of and 
mixing of PEG at elevated temperature (100°C), followed by a cooling to 25°C.  The 
point of visible turbidity in the solution was determined to be the point where phase 
separation was occurring, in a method similar to cloud point determination [76].    
Studies by Inamura are limited to more dilute polymer concentrations by the 
limitations of this method.  Concentrations prepared as a result of this study need to 
be dilute enough to be easily stirred, as well as transparent enough to ascertain 
whether turbidity is occurring.  Subsequently, formulations described by Inamura are 
limited to less than 30% total polymer for most molecular weights.  Inamura goes 
higher in concentration only for considerably lower molecular weights.  These results 
are not useful for the compositional determination of the phase limits for the 
preparation of a rigid construct for load bearing applications, however.  The following 
studies describe an understanding of the limits of composition for this incompatible 
system, using 
1
H-NMR methods for the separation of the PVA from the PEG 
component, in order to both understand the limit for formulation within the single 
phase region, as well as to understand the composition.   
5.3 Initial Dehydration Studies
Initial studies for determining the extent of dehydration that occurred as a result of 
incorporation of PEG into PVA solution began with a fixed water content of 60%.  
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The remaining two components (PVA and PEG) were varied around this water 
content to check for the extent of dehydration and the gels that were subsequently 
produced.  Early studies focused on dehydrating from an initial water content of 60%, 
since water contents greater than 60% seemed to produce gels weaker than was ideal 
for a nucleus replacement, from experience.  Unless otherwise noted, PVA refers to 
Mowiol 28-99; Mw=145kDa, manufactured by Kuraray Specialties Europe and PEG 
refers to Mw=10kDa manufactured by Fluka, Inc.  145kDa PVA is used for the 
majority of the early studies due to the elastic character that the gels exhibit from the 
high molecular weight network.
5.3.1 Experimental
PVA solutions were prepared in 500ml media bottles by autoclaving (50 minute 
cycle; 30minutes @ 121°C).  If solutions were non-homogeneous after autoclaving, 
samples were mixed again, using a spatula, and autoclaved again.  Mixing had to be 
performed by hand since automated mixers could not handle the viscosity.  At the 
point of complete solution formation, PEG was added and the mixture was allowed to 
cool to room temperature.  A first decant was performed, and weight of supernatant 
was obtained.  The mixture was autoclaved again, then equilibrated to 75°C, at which 
point more supernatant was poured off into the beaker with the material from the first 
pour.  Gels were then cooled to room temperature for 16 hours, overnight.  Gels were
blotted and portions were cut using a razor blade.  Mass loss on drying 
(16hours/105°C) was used to obtain water content (%w/w) for gel and supernatant.  
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Four formulations were prepared, with the intention of obtaining a full compositional 
analysis for each.  With a fixed water content of 60%,  PVA:PEG amounts for the 
four compositions was 25:15, 22.5:17.5, 20:20 and 10:30, where respectively, the 
amounts correspond to 25%PVA/15% PEG (formulation 1), 22.5%PVA/17.5%PEG 
(formulation 3), 20%PVA/20%PEG (formulation 2), and 10%PVA/30%PEG 
(formulation 4), so that one could obtain an understanding of the effects of either 
component on the dehydration process.
5.3.2 Results/Discussion
Data for phase separation is shown in Figure 5.2. For this case, a greater percentage 
of gel was seen with a smaller amount of PEG and a greater amount of PVA.  Gels at 
the left end of the graph were noted to be of a lower modulus, while gels at the right 
were noticeably more rigid and appeared to have lower water contents.   Mass loss on 
drying produced water contents for gels as in Table 5.1.  The remaining percentage 
for each formulation is PVA+PEG in an undetermined ratio.  Water content in gels 
can be seen to decrease with addition of greater amounts of PEG.  Water content in 
the supernatant also is seen to decrease with addition of PEG.  This is believed to be 
attributable to the fact that more supernatant is removed, as there is less PVA in the 
system to bind the water.
As previously described, PEG binds with two to three water molecules per repeat 
unit.  When the increased solubility and affinity of PEG for water is considered [4, 
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76], the amount of water retained by the concentrated PVA-rich phase is considered 
to be that which is more closely bound to this phase, a large percentage of which is 
dictated by the interactions and binding of PVA and water.  The relative binding 
potential of the PVA and water in the gel phase is described in the following sections, 
and is a function of the binding of both the PVA and PEG in the gel phase.  Future 
work describing the interaction of both PVA and PEG with water would be necessary 
in order to develop a model for the prediction of composition merely due to the 
binding potential of the two types of hydrophilic polymers, without the subsequent 
experimental production of a phase diagram.
NMR was proposed as a method for separating PVA and PEG in the solids, and the 
development of the understanding and methods necessary for the separation by mass 
of the PVA and PEG polymer components in the dried gel is described in the next 
section. 
5.4 Characterization of PVA/PEG Hydrogels via 
1
H-NMR
Poly(vinyl alcohol) (PVA) and poly(ethylene glycol) (PEG) have similar chemical 
structures, enough to inhibit simple means for separation of the two polymers.  For 
instance, once in solid form either can not easily be separated by solubility (since 
each is soluble in similar solvents), and the separation by melting point, would be 
very difficult.  Though early studies by Inamura et al [76] use separation via 
precipitation of PVA in a non-solvent (methanol), in order to separate the two 
polymers, the resulting ternary phase diagram is limited to relatively dilute solutions, 
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when compared to the formulations necessary to prepare a dense hydrogel.  A later 
study [4] describes the use of higher concentrations, but is limited to a lower 
molecular weight of PVA.  Similarly, a visual test for turbidity is used to determine 
the point where the phase separation occurs.  PVA solutions for the intended 
application must have a concentration sufficient in order to solidify in the gelled state 
into a material capable of supporting loads.  Whereas chemical crosslinking by 
methods such as combination with aldehydes and physical crosslinking by freeze-
thawing methods are capable of forming gels from more dilute solutions that will not 
deform under load, gel formation by the hydrogen bonded association of PVA gels 
occurs at relatively higher concentrations.  Since the solutions prepared are very 
concentrated and behave as semisolids, it was useful to develop an analytical 
chemical method for the separation of PVA and PEG, in order to obtain a correct 
compositional analysis of the product, as well as to obtain the full understanding of 
the phase separation that occurs.  Differences between the work of Inamura et al and 
the present work lie in both the concentrations evaluated (highly concentrated 
solutions were used in order to produce a modulus necessary for a load bearing 
biomaterial), as well as the establishment of a method of NMR analysis that allows 
for the relative quantification of each PVA or PEG polymer component after the gel 
phase has entered a state of rigid solidification.  
Proton nuclear magnetic resonance (
1
H-NMR), uses the alignment of protons within a 
magnetic field to probe the molecular structure of a sample [55]. By such techniques, 
the relative amount of two hydrogen containing functional groups may be discerned, 
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provided the correct understanding of the chemistry in relation to the spectra can be 
obtained.  Since PVA and PEG need to be separated in order to understand the 
quantities of each in a given phase, it was necessary to be able to obtain the 
percentage of each in a sample.  This would enable the analysis of trends between the 
initially mixed feed formulations and the resultant polymer gels and supernatants.  In 
short, a means for complete compositional analysis is necessary for determining the 
amount of PEG that becomes incorporated within the PVA gel, and the subsequent 
production of a phase diagram.
5.4.1 Experimental
A number of formulations are prepared for the initial mixture, or “feed”.   Samples 
were prepared as follows:  PVA solutions were prepared by combining PVA (Mowiol 
28-99 from Kuraray, Inc.; Mw=145kDa) and water in a 100ml media bottle and 
placing in an autoclave for a total cycle of 50 minutes, with 30 minutes at 121°C.  
After the cycle, solutions were mixed by hand, using a spatula.  Solutions were then 
re-autoclaved if they did not appear homogeneous.  After complete formation of 
solution, bottles were transferred to a temperature bath at 75°C where PEG (in flake 
form, from Sigma-Aldrich; Mw=10kDa) was added.  PEG was stirred in over two 
minutes using a spatula.  After PEG was added, the mixture was allowed to cool to 
room temperature.  A first decant was performed, and weight of supernatant was 
obtained.  The mixture was autoclaved again, then equilibrated to 75°C, at which 
point more supernatant was poured off into the beaker with the material from the first 
pour.  Gel was allowed to cool to room temperature.  Gels were blotted using a 
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Kimwipe at the time of being harvested, in order to remove supernatant, which would 
alter PVA/PEG ratio of the analyte.  Portions were cut using a razor blade.  Mass loss 
on drying (overnight @ 16hours/105°C) was used to obtain water content (%w/w) for 
gel and supernatant.  A portion of the dried samples was then dissolved in deuterated 
DMSO (DMSO-d6) at a target concentration of 3mg/ml and analyzed via 
1
H-NMR.
  
5.4.2 Results/Discussion
Chemistry of the 
1
H-NMR analysis was determined by selecting hydrogen-containing 
functional groups from molecules [97] similar to the ones being analyzed.  Peaks 
representative of hydrogens on both PVA and PEG were obtained.  Performing a few 
preliminary 
1
H-NMR runs for both PVA (Figure 5.3) and PEG (Figure 5.4) allowed 
for identification of possible peaks that are characteristic of each polymer.  The peaks 
that were observed to vary with composition of samples were compared with the peak 
positions from the literature (Figure 5.5).  
Hydrogens which are adjacent to a hydroxyl along the carbon chain match the 
molecule shown in the NMR Band Handbook reference [97] in Figure 5.6.  The 
bracket over the molecule depicted indicates the hydrogens which are identified as “a 
complex series of lines at 1.33ppm over a medium ppm range.”  This matches the
positions of the paired hydrogens along the PVA backbone.  Since the PVA that is 
chosen has a molecular weight of 145kDa, the number of these hydrogens per 
molecule is determined as follows:
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A molecular weight (Mw) of 145,000 g/mol with a repeat unit (M0) of 44g/mol has an 
average degree of polymerization of: Xw = Mw / M0  = 3291.6 [98].  This means that 
neglecting the effects of branching and endgroups, there are: 
3291.6 repeat units * 2 = 6583.2 of the hydrogens specified above.
Similarly, for PEG 10kDa, NMR spectra were obtained and peaks corresponding to 
selected hydrogens were identified by comparison with molecules in the same NMR 
Band Handbook [97].  Figure 5.4 shows a representative spectrum with the peak 
indicated.  The positions of the hydrogens on a similar molecule are indicated in 
brackets in Figure 5.7.
These hydrogens are described as forming “a doublet at ~3.68ppm”, which is seen as 
a singlet in Figure 5.4,  as splitting does not occur due to the similar environments of 
the two pairs on the PEG.  This is missing from the above chemistry due to the 
presence of the hydroxyl.
Since PEG has a molecular weight of 10,000 Daltons and a repeat unit of also 
44g/mol, the degree of polymerization is 10,000 g/mol / 44 g/mol = 227.2727.  This 
number is multiplied by four, since there are four in similar environments. Using 
“molecules / gram”,“number of hydrogens / gram” is obtained for each.  Ratio of 
PVA/PEG hydrogens is then obtained.
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When samples were prepared containing both PVA and PEG, both peaks were visible 
simultaneously.  The peak identified as PVA as well as the peak identified as PEG 
were seen to grow or shrink based on relative amounts in the material tested (See 
Figure 5.5).  This enabled calculations for the quantities of PVA or PEG in the final 
material.
5.4.3 Comparison of Actual Against Theoretical
In order to check the validity of the preceding interpretation of the NMR spectra, 
samples of known PVA and PEG amounts were analyzed and the outputted ratios of 
PEG and PVA peak areas were compared against the theoretical, calculated based on 
the concentration of functional groups present on a per weight basis.  Sample 
preparation was as follows:  Three check runs were performed where known amounts 
of PEG and PVA were weighed into scintillation vials.  Material was added to an 
approximate 6mg of total mass.  The relative masses of PEG and PVA that made up 
the 6mg were made to vary across three values for PEG/PVA as in Table 5.3.  Into 
each vial was added 2000µl (2ml) of DMSO-d6 via micropipette for a target 
concentration of 3mg/ml.  Material was dissolved by sealing the vials and heating to 
95°C in a laboratory oven for 15 minute intervals at which point the vials were 
removed and material was stirred.  This was repeated until the material appeared to be 
fully dissolved.  Samples were then transferred to NMR tubes manufactured by 
Sigma-Aldrich and tested using a 300MHz NMR.  
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Figure 5.9 also shows the results of 
1
H-NMR data for three separate, but identical 
batches.  
1
H-NMR data was shown to produce similar peak area ratios for each batch.  
The corresponding PEG/PVA ratio was determined through correlation with the 
proposed chemistry.  Though the points fall outside of the range of the theoretical and 
check runs, the basis for relating the peak areas to the PEG to PVA ratio is based on 
the same understanding of the chemistry, and can be inferred.  The curve can only be 
taken as proof of the understanding of the chemistry, and the fact that the PEG/PVA 
ratios correspond with the peak height ratios in a linear manner is only a result of the 
calculation method.  In other words, the positions of the three points on the curve 
corresponding to the samples are based on the chemistry and not simply an 
extrapolation of the graph. Positions of check runs were chosen based on accuracy 
for weighing of each sample. Upon analysis, the chemistry resulting from the peak 
area ratio that was obtained for these samples matched closely, the theoretical 
prediction (Figure 5.8).  
Finally, supernatant eluted from the system as a result of equilibration was similarly 
analyzed for presence of peaks attributable to PEG or PVA.  Spectra for supernatant 
showed no signs of PVA, indicating that any PVA eluting from the gel at this 
composition would be below the NMR detectable limit.  A representative 
1
H-NMR 
spectrum for supernatant is seen in Figure 5.9, below.  When the dried supernatant 
was analyzed via FT-IR, the spectrum closely matched PEG, with the exception of a 
peak at 1730cm
-1
, that is possibly due to degradation from the drying process (Figure 
5.10). 
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As a result of the compositional analysis of formulations via the methods described in 
the previous sections, final compositions were capable of being determined.  NMR 
allowed for calculation of PEG/PVA ratio using the method described (Figure 5.11). 
Lastly, formulations were adjusted to account for PVA vs. PEG content to produce 
the following full compositions in Figure 5.12.  Supernatant NMR was not performed 
in this case since it is a waste stream from the process.
5.4.4 Conclusions
A method for the separation of poly(vinyl alcohol) from poly(ethylene glycol) was 
established.  
1
H-NMR spectra for both PEG and PVA were determined to have 
representative peaks with areas that could be evaluated to determine the relative mass 
of either component in a sample.  Final composition was established for four feed 
compositions, enabling the production of a weight-per-weight ternary graphical 
representation of the 145kDa PVA and 10kDa PEG system to be contructed in the 
following section.  Amount of supernatant was observed to increase with addition of 
PEG to the system, whereas the water content of gels was concurrently observed to 
decrease. 
5.5 PVA/PEG Phase Characterization in a Range of Interest
Development of the NMR technique of the previous section allowed for 
compositional analysis of the dry polymer.  Separation of PVA and PEG on a mass 
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basis was possible and set the groundwork for initial attempts at understanding phase 
behavior of the material system.
Five formulations were prepared, The F1 formulation was chosen to be close to the 
20:20 formulation of the previous section.  With an understanding that PEG would 
dehydrate the system, to a varying extent, the relative amounts of PVA and PEG were 
varied, keeping the water content in the initial (“feed”) formulation constant.  
Keeping samples at a constant water content allowed for processing samples at a 
higher water content allowing for homogeneous composition, and allowing PEG to 
dehydrate to varying extents.  Samples include PVP as a stabilizer in 99:1 ratio, as 
well as barium sulfate, as would be added to make the gels radiopaque for 
visualization under fluoroscopy upon implantation.
5.5.1 Experimental
Hydrogels were prepared with initial compositions according to Table 5.3.  Mass loss 
on drying (%w/w) was performed over 16 hours at 105°C in order to obtain water 
content.  A portion of dried samples was then dissolved in deuterated DMSO 
(DMSO-d6) and analyzed via 
1
H-NMR to yield PEG/PVA ratio for the sample (n=3).  
Once mass loss on ignition (%w/w) was completed for samples at 650°C for 2 hours, 
barium sulfate content could be determined.  Knowing barium sulfate, and water 
content enabled total polymer mass to be calculated.  PEG and PVA percentages were 
determined from total polymer mass and PEG/PVA ratio from NMR.
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5.5.2 Results/Discussion
Final compositions of gels were obtained using the method described above and are 
reported in Table 5.4.
All formulations prepared as part of this study passed an injection test from the heated 
delivery gun using a 2.5mm ID cannula using the current method of internally heating 
the device to 95°C for 5 minutes.  Formulations ranged in viscosity, however.  
Viscosity behavior in relation to temperature will be discussed in the chapter on 
gelation in this thesis.  Trends observed between initial and final composition in the 
previous section were similarly observed.  With an increase in PEG in the feed, there 
is a corresponding increase in the amount of supernatant.  There is also a decrease in 
water in the final gel (see Table 5.4).  The water content for the supernatant is seen to 
remain within the same range for the samples in question.  For an increase in PEG in 
the feed formulation, water content in the final gel decreases, total solids content 
increases, PVA content remains within the 30-40% of the gel for all formulations, and
BaSO4 remains at 10-12% for most formulations.
The decrease in water content for samples with PEG addition is as to be expected 
with the increased affinity of PEG for water, however this trend is not observed 
across the last two samples in Table 5.4.  It is believed that the water content for the 
+3% samples is artificially low, due to water loss possibly from autoclaving.  
Compositional analysis for the formulations of this section are evaluated and 
compared in the rheometry section of this thesis. 
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5.6 PVA/PEG Phase Diagram 
One method for the representation of formulations in a ternary system is the 
placement of points on a triangular diagram, where each of the three corners 
corresponds to 100% of each of the three substances.  In this section, a similar 
approach as in Tompa et al [93] will be taken for the representation of a phase 
separating system consisting of a polymer (PVA 145kDa), a solvent (water) and a 
non-solvent, which is being considered to be PEG 10kDa, for the purposes of this 
study.  
5.6.1 Experimental
A number of formulations are prepared for the initial mixture, or “feed”.  PVA 
solutions were prepared by combining PVA (Mowiol 28-99; Mw=145kDa) and water 
in a 100ml media bottle and placing in an autoclave for a total cycle of 50 minutes, 
with 30 minutes at 121°C.  After the cycle, solutions were mixed by hand, using a 
spatula.  Solutions were then re-autoclaved if they did not appear homogeneous.  
After complete formation of solution, bottles were transferred to a temperature bath at 
75°C where Polyethylene Glycol (Mw=10kDa) was added.  PEG was stirred in over 
two minutes using a spatula.  Samples were allowed to cool to room termpature.  
After three hours of equilibration, supernatant was poured off into a beaker on a tared 
balance to obtain the mass of the supernatant.  Supernatant and gel were dried 
overnight for 16 hours at 105C, in order to obtain the water content of samples.  
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Samples of the same material were dried at room temperature over a longer period of 
time, for determining PEG/PVA content by NMR.   Gels had to be blotted using a 
Kimwipe at the time of being harvested, in order to remove supernatant, which would 
alter PVA/PEG ratio of the analyte.  Methods for preparation of samples for NMR 
were identical to in previous sections.  A target concentration of 3mg/ml was used.  
Samples were dissolved in DMSO-d6.       
Each formulation prepared is shown in Table 5.6 and corresponds to a point on the 
diagram in Figure 5.13.  These particular formulations were chosen based on the fact 
that there is a solubility limit for PVA in water.  Sets 1 through 9 in Table 5.6 each 
have a fixed water content.  It is important to note that due to the rules of phase 
separation that a gel composition for a point on the binodal could theoretically be 
reached by fixing the PVA/PEG ratio, and varying only water content, thus traveling 
in a straight line down the ternary diagram and tracing out the binodal with gels of 
compositions of varying water contents, while this is possible, from a theoretical 
standpoint, preparing PVA solutions of such a high concentration allows us to 
effectively dehydrate the system farther by choosing formulations with relatively 
more PEG over PVA.  For example, preparing a homogeneous PVA gel over 50% in 
concentration is made easier if more PEG is added to dehydrate more and result in 
lower water content for the gel.    
5.6.2 Results/Discussion
When the formulations described in Table 5.6 were prepared, gel formulations clearly 
defined a binodal at the right of the ternary diagram, as described in Figure 5.14.  
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Supernatant formulations were seen to form the binodal at the left axis.  Samples up 
to 90% water proved to have no detectable amount of PVA, via 
1
H-NMR, meaning 
the gel maintains the majority of its PVA throughout this dehydration process.   
As a result of this diagram, the understanding of the phase behavior of dense gels 
which can not easily be separated via precipitation in non-solvent was established, 
and methods translating to the characterization of similar systems are enabled.
5.7 Flory Chi Interaction Parameter
Though preparation of a ternary phase diagram through use of %w/w is useful for an 
understanding from a formulations standpoint, the understanding of solution theory as 
developed by Flory & Huggins as it relates to phase behavior is best described when 
an understanding of volume fraction of each polymer can be assessed.  Thus, in order 
to relate this understanding of the position of the binodal to the Flory-Huggins 
equation for ternary polymer systems, a conversion must be performed.  Density for 
each of the three components as described in Inamura [76] is used to relate w/w to
v/v.  Weight percent is divided by density to yield volume percent.  The densities 
given by Inamura are PVA: 1.27, H2O: 1.00 & PEG: 1.13. Using this method, a v/v 
ternary diagram is constructed in Figure 5.15.  The position of the binodal can be seen 
to shift upward slightly with conversion to v/v.  Considering the binodal is close to 
the solvent apex, a large value for χ can be expected.  χ  for the polymer-polymer 
interactions can further be expected to be positive for the most concentrated values, as 
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evidenced by phase separation in the dry state [76].   As the binodal moves toward the 
water apex, χ is expected to decrease. Increasing PEG molecular weight similarly 
results in a decrease in χ, as shown by the movement of binodals toward the water 
apex in Inamura [76]. The proximity of the binodal to the water apex is predicted by 
the relatively large PVA molecular weight, as predicted by Inamura.  
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Table 5.1 Water content of phases for selected formulations
Water Content in Gel (%)
Water Content in Supernatant 
(%)
Formulation Average (n=3) Std. Dev. Average (n=3) Std. Dev.
25:15 55.8% 2.5% 73.4% 1.0%
22.5:17.5 56.1% 4.5% 74.2% 2.6%
20:20 55.2% 2.0% 69.5% 0.4%
10:30 53.4% 2.6% 63.8% 0.2%
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Table 5.2 Weighed amounts for check runs and corresponding peak areas
Weighed amounts for Check 
Runs (mg) Peak Area Ratio
PEG PVA PEG/PVA Theoretical Actual
2.3 4 0.58 1.15 1.32
3.8 2.8 1.36 2.71 2.90
4.2 1.9 2.21 4.42 4.26
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Table 5.3 Initial composition (feed solution)
Sample Type (% PEG in Feed)
-5% PEG -3% PEG F1-145/10 +3% PEG +5% PEG
PEG (10kDa) 12.73% 14.73% 17.73% 20.73% 22.73%
PVA (Mowiol 28-99) 25.06% 23.06% 20.06% 17.06% 15.06%
PVP (Plasdone C-30) 0.20% 0.20% 0.20% 0.20% 0.20%
DI Water 55.00% 55.00% 55.00% 55.00% 55.00%
Barium Sulfate 7.00% 7.00% 7.00% 7.00% 7.00%
107
Table 5.4 Final gel composition
Sample Type (% PEG in Feed)
-5% PEG -3% PEG F1-145/10 +3% PEG +5% PEG
PEG 9.1% 8.5% 6.5% 7.7% 10.6%
PVA 31.8% 29.2% 33.5% 40.5% 33.8%
PVP 0.3% 0.3% 0.3% 0.4% 0.3%
DI Water 52.2% 51.9% 47.9% 40.7% 43.4%
Barium Sulfate 6.7% 10.1% 11.5% 10.7% 11.9%
% Solids 47.8% 48.1% 52.1% 59.3% 56.6%
% Polymer 41.1% 38.0% 40.6% 48.6% 44.7%
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Table 5.5 Water content of varying formulations
% Water (Gel) % Water (Supern)
Supernatant       
(% of total)
- 5% PEG 52.20% 62.80% 18.0%
- 3% PEG 51.90% 59.40% 18.9%
F1-145/10 47.90% 62.20% 33.3%
+ 3% PEG 40.70% 62.10% 38.0%
+ 5% PEG 43.40% 63.70% 47.7%
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Table 5.6 Formulation sets for ternary diagram.  All values are in %w/w.  60% 
water sample data (“Set 6”) was taken from a previous study.
Variables
Set 1
A B C D E
PEG (10kDa) 0.79 0.775 0.75 0.7 0.65
PVA (Mowiol 28-99) 0.01 0.025 0.05 0.1 0.15
DI Water 0.2 0.2 0.2 0.2 0.2
Variables
Set 2
A B C D E
PEG (10kDa) 0.74 0.725 0.7 0.65 0.6
PVA (Mowiol 28-99) 0.01 0.025 0.05 0.1 0.15
DI Water 0.25 0.25 0.25 0.25 0.25
Variables
Set 3
A B C D E
PEG (10kDa) 0.69 0.675 0.65 0.6 0.55
PVA (Mowiol 28-99) 0.01 0.025 0.05 0.1 0.15
DI Water 0.3 0.3 0.3 0.3 0.3
Variables
Set 4
A B C D E
PEG (10kDa) 0.59 0.575 0.55 0.5 0.45
PVA (Mowiol 28-99) 0.01 0.025 0.05 0.1 0.15
DI Water 0.4 0.4 0.4 0.4 0.4
Variables
Set 5
A B C D E
PEG (10kDa) 0.49 0.475 0.45 0.4 0.35
PVA (Mowiol 28-99) 0.01 0.025 0.05 0.1 0.15
DI Water 0.5 0.5 0.5 0.5 0.5
Variables
Set 7
A B C D E
PEG (10kDa) 0.29 0.275 0.25 0.2 0.15
PVA (Mowiol 28-99)
0.01 0.025 0.05 0.1 0.15
DI Water
0.7 0.7 0.7 0.7 0.7
Variables
Set 8
A B C D E
PEG (10kDa) 0.19 0.175 0.15 0.1 0.05
PVA (Mowiol 28-99) 0.01 0.025 0.05 0.1 0.15
DI Water 0.8 0.8 0.8 0.8 0.8
Variables
Set 9
A B C D E
PEG (10kDa) 0.09 0.075 0.05 0.03 0.01
PVA (Mowiol 28-99) 0.01 0.025 0.05 0.07 0.09
DI Water 0.9 0.9 0.9 0.9 0.9
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Figure 5.1 Formation of concentrated gel by phase separation
PVA solution
PEG
111
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Figure 5.2 Shows the percentage of gel remaining, after supernatant is decanted from 
the equilibrated mixture.
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Figure 5.3 H-NMR spectra for poly(vinyl alcohol) [97].
113
Figure 5.4 H-NMR spectra for poly(ethylene glycol).  
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Figure 5.5 H-NMR spectra of PVA-PEG mixture showing peaks for both PVA and 
PEG
115
Figure 5.6 Reference for PVA from NMR Band Handbook [97]
116
Figure 5.7 Reference for PEG from NMR Band Handbook [97]
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Figure 5.8 Comparison of check runs containing known amounts of PVA and PEG to 
the theoretical.  Datapoints showing results for three identical independently prepared 
batches are shown to overlap at the left of the graph.
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Figure 5.9 A representative H-NMR spectrum for supernatant eluting as a result of 
the equilibration process.
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Figure 5.10 FTIR spectrum of PEG and dried supernatant.  Supernatant shows an 
extra peak at 1730 cm
-1 
that is possibly due to degradation.
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Figure 5.11 Peak area ratios of the four formulations as determined by NMR.
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Figure 5.12 A – D show final composition for each of the four feed formulations 
described in section 4.5.1.
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Figure 5.13 Formulations for determination of ternary diagram
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Figure 5.14 Ternary phase diagram for PVA 145kDa / PEG 10kDa / water system
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Figure 5.15 Ternary diagram adjusted for v/v
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CHAPTER 6: SWELLING AND STABILITY OF PVA/PEG HYDROGELS
6.1 Introduction
To date, very little consideration has been given to the behavior of PVA/PEG gels 
with regards to swelling under varying osmotic conditions, such as the nucleus 
pulposus cavity.  An understanding of the swelling behavior of the wide range of 
possible PVA/PEG formulations has yet to be obtained.  For future development of a 
space-filling hydrogel implant, it is necessary to understand its interaction with the 
environment, in particular its volume change characteristics.      
Whether swelling is preferable in a nucleus replacement device is dependent on 
applicaton and is a matter of debate.  Moderate, controlled swelling may be 
acceptable depending on a number of conditions.  Understanding of swelling 
equilibrium of any implanted gel is critical to careful design as a prosthetic tissue, in 
order to control the pressure on nearby structures, as well as the potential migration 
beyond the site of implantation.  In order to ensure physical confinement of the 
implant, the method of delivery to the site (i.e. the size of the hole, or surgical defect), 
as well as the condition of the annulus, and presence of any fissures will determine 
whether the swelling material poses any risk to expulsion.  Elasticity of swelling 
material will further affect the ability to resist migration, as elastic forces resist 
extrusion of the device through fissures or defects.  Subsidence, or protrusion through 
the vertebral endplate, is also possible particularly for higher modulus implants, if 
swelling pressure is great enough.
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Though phase separation for a given range of PVA/PEG formulations has been 
described previously [4, 76], the response of the gel portion of these formulations to 
an osmotic concentration has not yet been established in the literature.  The response 
of the gel upon implantation in a physiologic osmotic environment has not yet been 
reported.   Further, there is no understanding as to how the osmotic equilibrium 
condition will change as the gel is separated from the supernatant and subjected to an 
osmotic potential. This section addresses swelling as generated from immersion of 
the PVA/PEG gel phase in an osmotic medium.  Based on a physiologic osmotic 
potential of 0.1-0.3MPa for nucleus pulposus tissue in the intervertebral disc, aqueous 
PEG solutions were prepared that simulate a 0.2MPa osmotic gradient [17, 18], and 
gels were subsequently immersed until equilibration, typically for 7 days, and change 
in volume was measured.     
It has been well known that PVA/PEG formulations containing a PEG molecular 
weight below 0.6kDa do not produce supernatant.  It is also known that the phase 
separation is dependent on the PEG molecular weight [4].   It is shown in this section 
that changing the PVA molecular weight has the ability to affect swelling behavior.  
It is also shown that PEG molecular weight affects the swelling behavior.  The 
challenge presented in this section is finding a gel system that not only behaves 
correctly as an in situ forming hydrogel with the correct physical and mechanical 
properties, but a system where the gel phase is sufficiently at equilibrium with the 
osmotic pressure of the disc so as to not imbibe water upon implantation and 
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effectively dissolve or change density in the disc space, or to swell to create problems 
in the surrounding pain generating areas.
6.2 Current Material System 
The first material system explored for swelling involves the formulation initially 
chosen for all early studies, where PVA Mw is 145kDa, and PEG Mw is 10kDa.  PVA 
molecular weight was chosen to be high for elasticity and network formation.  
Previous experience with cryogels has shown us that gels produced using low 
molecular weights of PVA are prone to fracture, and lack the resilient nature of the 
tangled molecular network.  Lower PEG molecular weights produced softer samples 
and PEG 0.4kDa did not provide the dehydration mechanism that was allowing the 
gels to be produced at such high concentrations.  
Formulations were varied relative to a reference formulation that had properties that 
were considered acceptable (Control 1).   Due to the ability of PEG to dehydrate PVA 
solution, gels having a range of PVA/PEG ratios in their feed formulations were 
prepared in order to scope this range in the first section (Formulations: Test 1-3).  The 
following section deals with varying water content (Formulations: Test 4 & 5).    
These formulations are then related to their final gel formulations to determine a trend 
in swelling.  A group of samples in the single phase region is then compared for 
swelling properties.
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6.3 Effect of Varying PVA/PEG in Feed Formulation
6.3.1 Experimental
Swelling studies in 0.2MPa PEGaq at 37°C were performed for three test formulations 
and one control over 14 days immersion, as described in Table  6.1.  Formulations for 
this portion of the study were chosen within the two phase region (formulations are 
shown on a ternary diagram in Figure 6.1).  PVA and PEG are varied to dehydrate the 
gel to different extents.  The standard method of gel preparation was used: 
autoclaving at 121°C and equilibration at room temperature for 3 hours, as described 
previously.  
Samples were heated to 95°C and molded into cylindrical molds (12mm dia. x 10mm 
height).  After 30 minutes of molding, samples were de-molded and measured for 
density via immersion in heptane using the following equation:
)(
)(
heptair
heptair
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m




The density of heptane (ρhept) used in this equation is 0.69 g/ml.  Masses were 
obtained in air or heptane for each using an analytical balance (Pinnacle Series, by 
Denver Instruments) fitted with a density determination kit.  Day 0 volume was 
calculated via mass/density.  Samples were then immersed separately in vials filled 
with 18g of de-ionized water that had been equilibrated to 37°C.  Samples were 
allowed to freely swell over 7 days in these conditions.  At the end of 7 days, samples 
were harvested and blotted to remove any excess water.  Volume was measured using 
the technique described previously, and V/V0 (Volume measured at post-swelling 
state divided by volume at pre-swelling state) was calculated.  Water content was 
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performed in the usual manner of loss on drying in an oven at 105°C overnight for 16 
hours.  Water content was obtained for the isolated gel, as well as the gel equilibrated 
in osmotic solution.   
6.3.2 Results/Discussion
Swelling reached equilibrium by 7 days (see Figure 6.2).  Dehydrating the gel by 
increasing PEG content in the feed formulation resulted in a decrease in swelling.  
Swelling decreased with water content in gel (at pre-swelling state), as can be seen in 
Table 6.2.  Equilibrium water content followed the same trend. When Test 1 was 
compared to the control, swelling was statistically similar.  Test 3 could not be 
prepared because the gel lost its mechanical properties and came apart, seemingly due 
to high barium sulfate content.  
Swelling is believed to be lower for more dehydrated gels, because the more 
concentrated gel forms a tighter network that resists the swelling pressure. These 
results follow the trend described by the Flory-Rehner relationship in Section 2.8 of 
this thesis, as the molecular weight between crosslinks is believed to increase and 
mesh size is believed to decrease with the increase in polymer content.   The equation 
relating molecular weight between crosslinks and the swollen equilibrium polymer
volume fraction tells us that as the polymer volume fraction increases, there is a 
corresponding precipitous drop in molecular weight between crosslinks, when other 
factors are viewed as being constant.  
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6.4 Effect of Varying Water Content
6.4.1 Experimental
Feed formulations having the same PVA/PEG ratio, but varying water contents as 
described in Figure 6.1 and Table 6.3 were evaluated for swelling.  Feed water 
contents decrease in 5% increments.  Swelling studies in 0.2MPa PEGaq at 37°C were 
performed for three test formulations and one control over 14 days immersion.  
Formulations for this portion of the study are also within the two phase region.  The 
standard method of gel preparation was used: autoclaving at 121°C and equilibration 
at room temperature for 3 hours, as described previously.  Gel cylinders (12mm dia. x 
10mm ht.) were heated to 95°C, then molded for 30 minutes at 37°C, demolded, then 
immersed in 18g of osmotic solution at 37°C.  Swelling (V/V0) was determined as 
described in the previous section.  Water content was performed in the usual manner 
of loss on drying in an oven at 105°C overnight for 16 hours.  
6.4.2 Results/Discussion
Water content in gels at pre-swelling state are seen to decrease along with swelling, 
as in Table 6.4 .  This is attributed to the tighter network structure of the more 
concentrated gel, as seen through dehydration in the previous section.  Test 6 
formulation could not be made since the PVA solution could not be prepared due to it 
being extremely concentrated.  On average for gels with varying water contents,  Test 
4 swelled to 3% less water and Test 5 swelled to 7% less water when compared with 
the control (see Figure 6.3).  Differences in swelling for Test 4 and Control were not 
statistically significant, however.    
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The position of the gel is anticipated to fall along the binodal prepared in the previous 
section.  When all samples are combined from the previous two sections, it can be 
seen in Figure 6.4 that there is a direct relation between swelling behavior and water 
content of the gel in the pre-equilibrated state for points along this binodal.  Gels of 
lower water content swelled less.  
These swelling results agree with the prediction from the Flory-Rehner relationship as 
described in the previous section. The results of decreased swelling for more 
concentrated formulations suggest that concentrating the gel phase has the effect of 
reducing the swelling, though to an extent that was considered to be too small (an 
84% vs 100% swelling increase) in order to be considered as a means for control over 
swelling properties.  The significance of these results is that the full reasonable scope 
of formulations is described to swell for this given PVA/PEG component system.  
Results further suggest that changes to polymer grade (possibly molecular weight or 
structure, as well as possibly degree of hydrolysis) are necessary in order to produce 
an implant that will not swell beyond the region of interest.  Swelling is also a direct 
indication of stability of the implant, as will be described later in this thesis.  Water 
imbibed from this process would also have deleterious affects on mechanical 
properties such as friability, modulus, wear resistance and fatigue life of the material.   
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6.5 Swelling and Stability within the Single Phase Region
6.5.1 Experimental
Three single phase compositions (see Table 6.5) also studied for gelation 
characteristics later in this thesis were tested for both swelling and dissolution in 
0.2MPa at 37°C (n=3).  Isolated gels at the pre-swelling state are expected to have 
water contents similar to that which are added in the initial feed formulations in order 
to clearly monitor equilibrium water changes.  Formulations were prepared at similar 
PEG contents that would not produce supernatant.  Other characteristics of sample 
preparation were kept the same. No supernatant was present to be decanted.
6.5.2 Results/Discussion
The gel with the lowest water content swelled less, similar to the previous study, 
however the highest water content swelled more (Formulations are shown in Figures
6.5a & b as datapoints on a ternary diagram, with corresponding swelling data 
annotated).  When percent dry mass loss was obtained for these samples, the samples 
with a reduction in swelling similarly showed an increase in dry mass loss (Figure 
6.5b).  Based on the gel integrity as part of the study, it was determined that the 
anomalous decrease in swelling for high water content gels was in fact attributable to 
the loss of mass, and the observation that a decrease in water content increases the 
stability of the gels was maintained for the single phase samples.  
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With the exception of the high water content samples, results for samples prepared 
within the single phase region match the trend observed for varying water content.  
No observable difference in swelling character or magnitude was noticeable for 
samples prepared via dehydration/phase separation, as in the previous section, in 
comparison to those prepared for this study, as a single phase.
6.6 Effects of Setup on Swelling
6.6.1 Introduction
Identical formulations of F1-145/10 that had been allowed to sit at room temperature 
were swelled in comparison to identical samples that had been recently melted and 
cooled, in order to view differences in the uptake of water for gels still undergoing the 
process of gelation.  
6.6.2 Experimental
Gels were used in the unmelted form, and had been allowed to set for five weeks at 
room temperature.  The same sample was used that had sat the same length of time in 
the unmelted state, was melted to its flowable “as delivered” state, molded for 30 
minutes at 37°C and allowed to swell.  Samples were swollen in 0.2MPa PEGaq
osmotic solution at 37°C, in sink conditions, where 12mm dia. x 10mm height gels 
were molded for the “as delivered” samples.  Cylinders of unmelted gels were cut to 
approximately the same size from longer cylinders and immersed in 18g of osmotic 
solution at 37°C.
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6.6.3 Results/Discussion
Differences in swelling were seen to result from differences in time that gels have 
been allowed to set before immersion in an osmotic medium.  See Figure 6.6.  
Significant differences in swelling can be seen between the two gel types.  These 
results suggest that PVA network formation is more advanced for gels that have been 
allowed to age, and that there is a long-term time-dependent effect to network 
formation that is critical to resisting swelling.  Results from this study are significant 
in that the implanted gel in the newly melted state cannot be viewed as having the 
same swelling properties as a gel that is prepared as a preformed device (i.e. the 
“unmelted” sample that had been allowed to gel for five weeks) and implanted.  
Swelling must be viewed in relation to the thermal history of the gel, and the time that 
has elapsed since cooling is critical to properly evaluating the swelling characteristics.  
For the purposes of this thesis, the gel is designed to be delivered in the melted state 
and subjected to the intervertebral disc swelling pressures immediately following 
delivery, at the time that the gel is still cooling to physiologic temperature.  
6.7 Swelling at Varying PVA Molecular Weight
6.7.1 Introduction
Swelling affects at varying PVA molecular weight was determined.  Preparation of 
samples of PVA gels with decreased molecular weight yielded samples that swelled a 
relatively smaller amount (volume increase of 55% in phosphate buffered saline 
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solution), however the material lacked structural integrity, was brittle and friable.  
This decreased swelling was in contrast to previous gels prepared from higher 
molecular weight PVA.   Differential scanning calorimetry (DSC) is used to compare 
differences in thermal transition with swelling.  
6.7.2 Experimental
6.7.2.1 Swelling
Concentrated PVAaq gels (i.e. 50% w/w PVA in water) were prepared at varying PVA 
molecular weights (13-23kDa, 125kDa & 195kDa; the first PVA is a 98% hydrolyzed
grade branded as Aldrich, and the second two are Mowiol 20-98 & 56-98 
respectively; all are fully hydrolyzed PVA grades obtained through Sigma-Aldrich).  
In the test, aqueous solutions of PVA were prepared in an autoclave and injected into 
11mm diameter x 100mm height stainless steel cylindrical molds.  These cylinders 
were allowed to cool to room temperature for 16 hours, and then cut to 1mm height 
cylinders and immersed in 0.2MPa osmotic solution at 37°C for 7 days, in order to 
track swelling.  Photos of the cylinders after 7 days of swelling are shown in Figure 
6.7.
6.7.2.2 Differential Scanning Calorimetry (DSC)
A 50% aqueous solution of 12-23kDa PVA was prepared in an autoclave. The 
solution was allowed to stand at room temperature overnight for 16 hours, after which 
point the material was tested using the following method:
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Step 1.  Initial temperature = 25°C
Step 2.  Temperature ramp:  5°C/min to 95°C
Step 3.  Temperature ramp:  5°C/min to 25°C
Step 4.  Temperature ramp: 5°C/min to 95°C
The same process was repeated for higher molecular weight material:  A 50% w/w 
aqueous solution of 145kDa PVA was prepared in a similar manner, allowing it to 
cool by standing at room temperature overnight for 16 hours.  Samples of high 
molecular weight were tested using the method described above.
  
6.7.3 Results/Discussion
Samples with high molecular weight PVA were observed to swell considerably.  It 
can be seen in Figure 6.8 that swelling is dramatically lower for 13kDa samples 
(26.0% increase in volume), when compared with 125kDa and 195kDa samples 
(61.8% and 65.2%, increase in volume, respectively).  Despite swelling reduction for 
the 13kDa samples, mechanical properties could be observed to decrease.  Many 
13kDa samples developed cracks as part of the swelling process.  Samples of 125kDa 
and 195kDa were elastic and did not fragment easily.
DSC was performed for the low molecular weight material and compared with the 
high molecular weight, in order to show any network effects, such as an endotherm 
from crystallization that might indicate more physical crosslinking that would lead to 
a lower molecular weight between crosslinks, as anticipated by the Flory-Rehner 
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relationship.  Two transitions were noticed for low molecular weight material (12-
23kDa), the first at ~60°C and the second at 84°C (see Figure 6.9).  The results of an 
evaluation using the same DSC method with 145kDa PVA are shown in Figure 6.10.  
None of the same transitions noticed for the low molecular weight were seen in the 
results for the test using high molecular weight.  It is described by Muller et al, that 
there is an improved crystallizability of PVA at low molecular weights (<4.4kDa) due 
to the varying entropy and mobility of the smaller molecules [99].  It is 
understandable that due to these transitions and the observed brittle properties of 
samples that a secondary form of crystallization occurs with molecular weights below 
a certain value.
By decreasing the PVA molecular weight enough, swelling is believed to be 
mitigated.  A balance must be obtained, between molecular weight swelling effects, 
(which favor low molecular weight PVA, see Figure 6.11), while avoiding the 
characteristic friability and brittle behavior of swelled low molecular weight PVA 
gels.  The proposed solution is that samples with good structural integrity and 
swelling properties would be somewhere between the 13kDa and 125kDa samples, as 
described in the next section.
6.8 Optimization of PVA Molecular Weight for Minimal Swelling
6.8.1 Introduction
In order to best balance the friability observed in samples with low molecular weight 
PVA, and swelling observed in samples with high molecular weight PVA, swelling 
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studies were performed for formulations having intermediate molecular weights for 
PVA (27-61kDa range).  
6.8.2 Experimental
A first study was performed where identical formulations were prepared using 
identical mixtures of the F1-x/10 formulation, where x = 61kDa PVA (“Test”) for one 
formulation and x= 145kDa PVA (“Control”).  Samples were evaluated for swelling.  
A second study was prepared comparing against even lower molecular weights of 
PVA (27kDa).  Different formulations were prepared (F3 & F4 in Table 6.1), in order 
to reduce the water content for this gel.  Swelling was performed using the methods 
previously described, in 0.2MPa PEG solution at 37°C.
  
6.8.3 Results/Discussion
Results in Figure 6.12 suggest that the same reduction in swelling that had been seen 
previously for low molecular weight PVA is not seen in 61kDa samples.  61kDa 
samples were also not brittle, suggesting the low molecular weight crystallization was 
not exhibited for these samples.  When 61kDa was compared with 145kDa there was 
no difference in swelling (see Figure 6.12).
Lower water content formulations were prepared for even lower molecular weight 
PVA (Mowiol 4-98; 27kDa), in order to decrease swelling further, since swelling was 
seen in previous sections to be affected by water content, and low molecular weight 
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solutions formed noticeably weaker gels.  PEG grade is 10kDa, and all other 
components are same. Lower water content formulations F3 and F4 were chosen in 
order to increase viscosity for lower molecular weight material.  As shown in Figure 
6.13, swelling for F3 and F4 was similar for both at ~30-33%.  Samples prepared 
using 27kDa PVA retained their general shape (Figures 6.14a & b) and had a 
relatively high modulus.  Sample modulus was measured at 1.8MPa.  Samples were 
inelastic and brittle, however.  When tested in compression, the sample fractured
(Figure 6.14c), which is an unacceptable mode of failure for a nucleus replacement.  
More elastic samples with a higher elongation at break are necessary.  Final sample 
compositions were not determined due to the brittle behavior and unacceptable nature 
of the samples.
It should be noted that samples of lower molecular weight PVA were observed to 
have a difference in melting characteristics.  Samples did not melt to a smooth texture 
when being injected into the mold, suggesting that the melting temperature was 
higher and the flow was limited to melt fracture.  The incomplete melting possibly 
had an affect on the ability of the gel to form up correctly.  If melted to a greater 
extent the material may seem less brittle and display better mechanical properties, 
however it was outside of this study to increase the injection temperature, as the gel 
must be designed to have a delivery temperature low enough for implantation.
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6.9 Swelling at Varying PEG Molecular Weight
As mentioned above, phase equilibrium exhibited by the gel/supernatant system is 
affected by the molecular weight of PEG that is chosen [4].  It is reasonable to 
assume that since the equilibrium of the gel with the supernatant is affected by 
changing PEG molecular weight, so would the equilibrium of the gel in other 
environments, namely in an osmotic environment such as the disc, or the 0.2MPa 
PEG solution that it being tested.   This is at least in part due to the presence of the 
molecular weight term in the osmotic virial equation.
6.9.1 Experimental
A swelling study was performed, where the F3 formulation, as described in Table 4.1 
and the previous section was prepared using three different PEG molecular weights.  
The PVA molecular weight was fixed at 61kDa, and the PEG molecular weight in 
each formulation was 0.4, 1 or 10kDa.  Samples were molded into cylinders over 30 
minutes then immersed in 0.2 MPa osmotic solution at 37°C for 7 days and swelling 
(V/V0) was tracked as in the previous studies.  
6.9.2 Results/Discussion
Results from the 7-day swelling study (see Figure 6.15) showed that lower molecular 
weight PEG resulted in a lower degree of swelling.  The 0.4kDa PEG produced no 
swelling at this formulation (V/V0=0.98), whereas 1kDa PEG samples produced a 
V/V0 of 1.31, and 10kDa PEG had a V/V0 of 1.90, which was close to our F1-145/10 
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control (V/V0=1.97).  Previous data has shown that swelling decreases with an 
increase in water content.  Pre-swelling water contents for 0.4kDa and 1kDa 
respectively had been 46.4±0.9% and 40.4±2.1% which is opposite to the direct 
correlation of water content and swelling.  This further supports the effect of a strong 
direct correlation between PEG molecular weight and swelling.        
Mass loss was similarly measured for these samples.  0.4kDa PEG had a 36±0.3% dry 
mass loss, though integrity of samples was good after swelling.  It is likely that the 
majority of mass lost due to swelling was 0.4kDa eluting from the sample during 
equilibration.  Samples with 1kDa PEG exhibited only a 9.4±3.0% dry mass loss.  As 
will be seen in the next section, this trend is opposite to what is observed when 
swelled in de-ionized water for formulations and is attributed to the presence of the 
osmotic environment, which swells the material less, trapping higher molecular 
weight in the gel phase.
6.10 Effect of PEG on Swelling and Stability within the Single Phase Region
6.10.1 Experimental
Swelling studies were performed for single phase “G” in Table 6.5 at varying 
molecular weights of PEG (0.4, 1, 10, 20 & 35 kDa).  Samples were each prepared by 
the standard method of heating in an autoclave at 121°C, and cooling to room 
temperature afterward.  No supernatant was present to be poured off.  Swelling and 
dry mass loss were obtained, as previously described, with the exception that samples 
were swollen in de-ionized water at 37°C for 7 days.  Water was dried at the end of 
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the study to look for signs of eluting PEG via FTIR.   Mass loss studies for three 
formulations in 0.2MPa osmotic solution were also prepared separately and are used 
for comparison.
6.10.2 Results/Discussion
An increase in molecular weight was seen to produce an increase in swelling, with a 
maximum at 10kDa (see Figure 6.16).  Dry mass loss at 7 days immersion was seen 
to increase with PEG molecular weight, which is understandable due to the greater 
amount of swelling exhibited by gels with higher molecular weight PEG.  It is 
possible that the effect observed in this case for de-ionized water was not previously 
observed for dry mass loss in osmotic solution because the network was not able to 
expand as much in the osmotic environment, effectively keeping in more material that 
would otherwise elute out.  Mass loss for formulations prepared in 0.2MPa solution 
(see Figure 6.17) shows a trend where higher molecular weight PEG is retained after 
swelling.
   
6.11 Statistical Treatment of Swelling Data
Available data for formulations under consideration was evaluated statistically in 
order to properly define resulting trends from the available input factors, in particular, 
those of component percentage, as well as component grade (i.e. molecular weight).  
F1, F3 & F6 from Table 4.1 are prepared and Table 6.6 shows the swelling data 
generated across the range of formulations, and molecular weights of materials.  
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Figure 6.18 shows the main effects plot resulting from that data.  Other than the affect 
of PEG molecular weight, no other major factor was shown to contribute to swelling.  
Feed composition was shown to not be as significant a variable in the formulation 
range of interest.  In ruling out very low PVA molecular weights because of 
brittleness, there was little affect varying between 61kDa and 145kDa PVA.  
A main effects plot was generated for swelling data using the available factors for 
composition.  A one way ANOVA was performed to determine significant factors to 
swelling.  With the exception of PEG molecular weight (P(2Tail) = 0.002), each of 
the factors (H2O, PVA, PEG, PVA-molecular weight, PEG-molecular weight) 
showed little or no affect on swelling.
Main effects plot data regarding PEG molecular weight showed the same result as 
had been highlighted in previous sections, where the incorporation of lower molecular 
weight leads to a lower degree of swelling.  The resulting effects of a greater 
molecular weight polymer, such as PEG, that is both very flexible, and hydrophilic to 
the extent of being able to bind large quantities of water and swell considerably [6, 
71, 72].  Larger molecular weight PEG will result in a larger hydrodynamic radius for 
the swollen polymer.  In other words, a shorter linear polymer of the same chemistry 
will result in a smaller radius when in its swollen state.  Larger polymers generate a 
swelling pressure that follows from their hydration and expansion.
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Table 6.1 Initial feed formulations for samples with varying PVA vs. PEG ratio
Ctrl-1         
(F1-145/10)
Test-1   
(0.75PVA/PVP)
Test-2 
(0.5PVA/PVP)
Test-3 
(0.25PVA/PVP)
PVA 20.1% 15.0% 10.0% 5.0%
PVP 0.2% 0.2% 0.1% 0.1%
PEG 17.7% 22.8% 27.9% 32.9%
BaSO4 7.0% 7.0% 7.0% 7.0%
Water 55.0% 55.0% 55.0% 55.0%
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Table 6.2 Swelling for varying PVA vs. PEG samples.
Ctrl-1 Test-1 Test-2 Test-3
Average
Std. 
Dev. Average
Std. 
Dev. Average
Std. 
Dev. Average
Std. 
Dev.
Water Content in 
Gel (Pre-Swelling) 50.4% 0.6% 45.4% 1.0% 40.8% 0.5% N/A N/A
Equilibrium Water 
Content (14days) 74.5% 0.3% 71.0% 0.1% 67.2% 2.3% N/A N/A
Swelling 201.6% 5.7% 197.6% 1.9% 184.3% 6.4% N/A N/A
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Table 6.3 Initial feed formulations for samples with varying water content.
Control-1      
(F1-145/10)
Test-4              
(-5% Water)
Test-5                   
(-10% Water)
Test-6                
(-15% Water)
PVA 20.1% 22.3% 24.6% 26.8%
PVP 0.2% 0.2% 0.2% 0.3%
PEG 17.7% 19.7% 21.6% 23.6%
BaSO4 7.0% 7.8% 8.6% 9.3%
Water 55.0% 50.0% 45.0% 40.0%
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Table 6.4 Swelling for varying water content samples.
Control-1 Test-4 Test-5 Test-6
Average
Std. 
Dev. Average
Std. 
Dev. Average
Std. 
Dev. Average
Std. 
Dev.
Water Content in 
Gel (Pre-Swelling) 50.4% 0.6% 46.4% 1.0% 44.1% 0.9% N/A N/A
Equilibrium Water 
Content (14days) 74.5% 0.3% 72.1% 1.1% 68.3% 3.5% N/A N/A
Swelling 201.6% 5.7% 200.6% 2.3% 193.8% 6.5% N/A N/A
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Table 6.5  Three initial feed formulations prepared within the single phase region.
Variables
F G H
Composition 
variables
Mmol % Mmol % mmol %
PEG (10kDa) 0.625 6.25 0.625 6.25 0.555 5.55
PVA  (Mowiol 28-99) 0.221 32.01 0.267 38.75 0.314 45.56
DI Water 3427.1 61.74 3052.9 55 2713.8 48.9
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Table 6.6 Data set for main effects plot
Formln
PVA-MW 
(kDa)
PEG-MW 
(kDa)
H2O 
(wt.%)
PVA 
(wt.%)
PEG 
(wt.%)
Swelling 
(V/V0)
F1 61 10 59.20 21.71 19.09 1.90
F1 145 1 59.20 21.71 19.09 1.26
F1 145 10 59.20 21.71 19.09 2.00
F6 61 0.4 53.27 21.49 25.25 0.94
F6 145 0.4 53.27 21.49 25.25 1.08
F6 145 1 53.27 21.49 25.25 1.40
F3 61 0.4 48.44 21.74 29.82 1.00
F3 61 1 48.44 21.74 29.82 1.30
F3 61 10 48.44 21.74 29.82 1.55
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Figure 6.1 Feed formulations from Tables 6.1 & 6.3, as 
depicted on a ternary diagram.  
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Figure 6.2 Volume change (expressed as final volume over initial volume) for 
swelling in 0.2 MPa osmotic solution (  Control,  Test 1, &  Test 2).
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Figure 6.3 Swelling for formulations with varying water content  (  Control, 
Test 4 &  Test 5)
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Figure 6.4 Ternary diagram showing swelling (% of initial volume) at varying water 
content on diagram.
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Figure 6.5 a) Swelling for formulations that were prepared to result in a single phase 
(compositions F, G, & H). and b) Percent dry mass loss for formulations prepared to 
result in a single phase.  Previous formulations are included for reference.
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Effects of Setup Time on Swelling                                                            
"Stick" (Unmelted) vs. "As Delivered" (Melted)
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Figure 6.6 Effects of gel setup time on 7 days of swelling in 0.2 MPa solution.  Gels 
melted from the stick at 95°C for delivery were compared against unmelted sticks 
stored for 5 weeks(  unmelted & melted).  
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Figure 6.7 Photos of 50% PVA gels at 7 days swelling at varying molecular weights.  
From left to right: 13kDa, 125kDa and 195kDa samples.
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Swelling by PVA Molecular Weight (50% Preformed PVAaq Gels)
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Figure 6.8 Swelling of 50% PVAaq gels ( 13kDa, 125kDa &  
195kDa)
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Figure 6.9 DSC of low molecular weight PVA (50% aq.) after being allowed to stand 
at room temperature for 16 hours.  Two transitions are visible.
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Figure 6.10 DSC Results for neat 50% aqueous gels of 145kDa PVA (dashed line).
Results for neat 50% aqueous 12-23kDa PVA are included for comparison.
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Figure 6.11 Low molecular weight (at left) vs. high molecular weight (at right) 50% 
PVAaq gels at 7 days of swelling.  The low molecular weight PVA sample has 
retained its shape but is brittle whereas the higher molecular weight is elastic, but has 
swelled.  
161
PVA MW Comparison
1
1.2
1.4
1.6
1.8
2
2.2
0 1 2 3 4 5 6 7 8
Time (days)
V
/V
0
Figure 6.12 Swelling with varying PVA molecular weights gels (  61kDa &
145kDa)
162
Injectable Nucleus Components Added w/27kDa PVA              
Equilibration at 0.2 MPa
1
1.2
1.4
1.6
1.8
2
2.2
0 1 2 3 4 5 6 7 8
Time (Days)
V
/V
0
Figure 6.13 Swelling in 0.2MPa PEG solution prepared using 27kDa PVA ( F3-
27/10, F4-27/10, F1-145/10)
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Figure 6.14 a) showing a 27kDa-PVA sample (Formulation is F3-27/10) at Day 0; 
and b) Day 3; Figure c) shows the sample fractured after compression testing.
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Varying PEG Molecular Weight - F3 (61k)
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Figure 6.15 Swelling for the F3-61/x formulation prepared using three different 
molecular weights of PEG: x = PEG-0.4kDa; PEG-1kDa; and PEG-10kDa
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Figure 6.16 Single phase formulation “G” a) swelling upon immersion  and b) dry 
mass loss upon immersion (both at 7 days in de-ionized water) with a range of PEG 
molecular weights  
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Figure 6.17 Percent dry mass loss in 0.2 MPa osmotic solution
Dissolution (% Dry Mass Lost) in 0.2MPa Osmotic Solution
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Figure 6.18 Main affects plot showing factors (composition, as well as PVA & PEG 
molecular weight and response (swelling)
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CHAPTER 7: GELATION
7.1 Introduction
As described earlier, cooling of the concentrated aqueous PVA/PEG system from the 
sol produces a gelation mechanism with a rheology that has yet to be appropriately 
characterized.  Differences between neat aqueous PVA solutions and the PVA/PEG 
system, with regard to the transitional state from sol to gel are defined in the 
following sections.  Based on the results generated, comparisons for viscosity 
transitions for pre- and post- gelation are able to be made.  Quantifications of the 
relative size of transitions are also able to be made with respect to formulations.  The
temperatures of the transitional state, as well as the factors affecting it are able to be 
defined, enabling tailoring of setting profiles to material application. Gelation data 
are collected at the point of implantation.  It is important to note that gelation 
concerns implants in the newly delivered, or pre-swelled state.  As described earlier 
in the swelling section of this thesis, there is an effect of time the material is allowed 
to gel on the resultant swelling properties.    
7.2 Gel Point
7.2.1 Experimental
An AR2000 rheometer (TA Instruments) with 40mm diameter crosshatched parallel 
plates was used to test samples in oscillatory shear (0.5% strain/s) (see Figure 7.1).  
Cross-hatching was used to fix samples into position for the oscillatory strain setup.  
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The gap between plates was set at 750µm.  Temperature was controlled using a 
Peltier plate heating system.  Gel could not be easily cut at the edges of the testing 
apparatus, since it was very elastic.  Gels within this section are prepared with 
145kDa PVA (Mowiol 28-99, purchased from Kuraray, Inc) and 10kDa PEG 
purchased from Sigma-Aldrich.  Gel point was determined using a temperature ramp 
from 95 to 37°C over 20 minutes (2.9°C/min), with an initial 5 minute equilibration at 
95°C.  The crossover point of the storage and loss modulus is defined in ASTM 4473 
as the “gel point”[100].  
7.2.2 Results/Discussion
As shown in Figure 7.2, setting behavior of PVA/PEG gels shows an increase in 
storage modulus with a decrease in temperature.  Secondary effects become 
noticeable in the region below 42°C as the storage modulus increase becomes much 
more dramatic.  Due to similarities between the storage and loss modulus at higher 
temperatures, the crossover point had showed variability (65-84°C was the range for
measured crossover points when four identical samples were evaluated), and it is
shown that due to the close nature of the two curves, that differences between storage 
and loss modulus at higher temperatures were not significant.  Storage modulus
dominated below this temperature, indicating gelation for samples cooled past this 
point.  For averaged samples (n=5; Figure 7.2), storage and loss modulus were within 
one standard deviation at temperatures above 61°C.  Below 61°C, storage modulus 
becomes the dominant term contributing to total complex modulus.  Gelation can be 
seen to undergo the steep incline in modulus at ~45°C, for both storage modulus, and 
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loss modulus to a lesser extent.  The source of the transition will be described in the 
following sections with respect to the combined viscoelastic term of complex 
viscosity.  The chemical and physical basis for the shape of this transition will be 
further described in the following sections, as it relates to viscosity measurements in 
the literature describing similar transitions, such as the viscosity drop and interference 
of PVA hydrogen bonding for the PVA systems observed by Briscoe et al (see 
Section 2.9 of this thesis) [6].  In this work, Briscoe et al describes a solubility 
transition where apparent viscosity in the high temperature state decreases due to a 
decrease in the hydrogen bonding interaction between PVA and water, as a result of 
the incorporation of a second component such as PEG which is a known plasticizer 
that competes for water affinity in the system [5].
7.3 Temperature Effects on Viscosity
7.3.1 Experimental
Complex viscosity was calculated from dynamic rheometry data as η* = η` +  iη``, η` 
is dynamic viscosity, and η`` is the remaining imaginary term [101].  η` is defined as 
the loss component divided by angular frequency G”/ω; and similarly η`` is defined 
as G`/ω.  Complex viscosity is used to combine both viscous and elastic effects 
during gelation.
In a first test to evaluate the effects of temperature on complex viscosity, a 
temperature ramp was performed using the same method and experimental setup as in 
the previous section (crosshatched parallel plates, 0.5% Strain; 1 Hz; 0.75mm plate 
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gap.  The method used was 95°C for 5 minutes and a ramp over 20 minutes from 
95°C-37°C).  A sample of PVA gel of the same PVA/water ratio (equal to 43% w/w) 
was included as a control.     
In a second test, complex viscosity was plotted for the same formulation at a range of 
temperatures, over time.  Again, this experiment was performed using a parallel plate 
rheometer in oscillatory shear in a setup similar to above.  Methods were changed 
however to include rapid temperature jumps, cooling to each of four temperatures: 37, 
45 & 70°C.  A sample was also held at 95°C as a control.  Each was then followed by 
30-minute temperature equilibration steps where viscosity was monitored.   As part of 
this test, viscosities for multiple replicates were also obtained for samples after they 
had equilibrated to one of three temperatures of interest (37, 45 and 70°C; see Figure 
7.6).  The substantial increase in viscosity experienced after temperature equilibration 
for samples at 45°C could once again be seen between the initial and five minute 
timepoints.   
7.3.2 Results/Discussion
For the first test (results are shown in Figure 7.3), the temperature response for 
viscosity is evaluated over a controlled cool.  The gel (F1-145/10) can be seen to 
undergo a transition at 45°C that results in a decreased apparent viscosity at high 
temperatures (Figure 7.14) reminiscent of that described previously in this thesis in 
data from Briscoe [6].  At this higher concentration this effect corresponds to a setting 
transition for this component system.  This data is compared with the viscosity 
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profiles of aqueous PVA solutions as shown in Figure 7.4.   The current PVA/PEG 
formulation (F1-145/10; shown as hollow circles) is compared with that same final 
formulation without PEG (solid circles).  This PVA gel corresponds to the same 
PVA/water ratio, or 43% w/w.  The high temperature (or “delivery”) viscosity 
(viscosity at T>42°C) is seen to be dramatically lower for samples containing PEG, as 
compared to those without.  The PVA control can be seen to exhibit a steady viscosity 
increase without transition, as predicted by the literature for high degree of hydrolysis 
material [6]. 
For the second test, viscosities were held at varying temperatures over short time 
intervals (as shown in Figure 7.5).  In most cases, the viscosity can be observed to 
undergo two types of behavior, the first type, which is largely temperature dependent, 
and the second type, which is time dependent.  The graphs in the figure were 
observed to reach their respective temperatures at the instant in which the viscosity 
changes to a much shallower slope and begins to only slowly creep upward with time.  
An exception to the temperature behavior described can be seen for 45°C samples, 
where the viscosity does not immediately reach a steady value (as indicated in the 
circle in Figure 7.5).  The lag in viscosity experienced for 45°C samples can be seen 
to be at the location of the transition described in the accompanying study.  It is not 
clear why viscosity does not immediately stabilize at this given temperature; however 
it may be due to instability from the gelation transition region at which temperature it 
is located.  Figure 7.6 shows averaged data for gels equilibrated at varying 
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temperatures. It is useful to note the fact that little viscosity change occurs over short 
times at 95°C allows for maintaining the flowability of the gel prior to testing.     
7.4 Relationship of Phase Behavior to Gelation 
7.4.1 Introduction
The following sections will describe the temperature dependent viscosity transition 
observed in the previous section, with respect to changes in components and 
formulation.  Gels are prepared with the intention of tracing across a range of 
formulations in order to determine the setting transition with respect to composition, 
for a given system of component materials.  The following studies explore the change 
from a PVA/PEG phase separating system exhibiting the transition previously 
described, to the PVA gel without PEG exhibiting no transition, similar to that 
described in Figure 7.4.   
7.4.2 Experimental
7.4.2.1 Comparison between PVA and PVA/PEG Transitions
Samples were prepared as described previously in the sample preparation section with 
little deviation (145kDa PVA, 10kDa PEG).  Formulations are as shown in “A” 
through “E” in Table 7.1, in varying millimolar quantities of PEG.  Formulations 
were varied with respect to a given “reference” formulation.  This is described as the 
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PEG 1.0 formulation.  A sample containing no PEG is also included (“Control”) for 
comparison.  The control consists solely of aqueous PVA solution. 
Rheometry measurements were performed using an AR2000 rheometer (TA 
Instruments) with 40mm diameter crosshatched parallel plates which tested samples 
in oscillatory shear (0.5%strain; 1 Hz) using the method as previously described 
(95°C to 37°C / 2.9°C.min).  Cross-hatching was used to fix samples for the 
oscillatory strain setup.  Gap between plates was set at 750µm.  Temperature was 
controlled using a Peltier plate heating system. 
7.4.2.2 Affect of Water Content on Setting Transition
In a second study, three more formulations were prepared within the region 
determined by the position of the binodal to be single phase.  Water content in the 
gels was varied.  PEG content was similar for each formulation.  Table 6.5 describes 
the formulations.  Figure 7.7 shows the formulations along with the first set on a 
ternary diagram, along with the approximate position of the binodal. 
   
7.4.3 Results/Discussion
7.4.3.1 Comparison between PVA and PVA/PEG Transitions
Formulations range on either side of the point where supernatant begins to form.  In 
Table 7.1, formulations with PEG concentrations for sample group D and E form 
supernatant, whereas formulations with PEG concentrations less than this do not.  
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Figure 7.8 shows gels within the single phase region, with less PEG than will produce 
supernatant.  The gels are observed to undergo a decrease in viscosity as PEG is 
added in increasing amounts.  The resultant effect is a lower viscosity for a higher 
polymer content due to the plasticization created by the presence of small amounts of 
PEG.  This reduction in viscosity for small PEG additions is to be expected when the 
results of Lim et al are taken into consideration [5], where an interference occurs in 
the ability of PVA and water to hydrogen bond.  This reduction in hydrogen bonding 
produces the observable decrease in apparent viscosity with PEG addition.
Figure 7.9 shows the samples as the PEG content is increased further into the two 
phase region.  The samples exhibit an increasing transition, as the PEG dehydrates to 
successively lower water contents for the gels.  
7.4.3.2 Affect of Water Content on Setting Transition
Figure 7.10 shows samples prepared in the single phase region.  Setting transition is 
seen to increase, as water decreases.  Based on this brief study, gels prepared as a 
single phase were observed to exhibit similar gelation profiles to phase separated 
ones. Setting transition increased with a decrease in water content in the single phase 
region.
For increasingly concentrated gels the viscosity transition becomes visible.  These 
results match those described in Briscoe et al, in that the transition is a concentration 
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dependent effect.  This behavior describes a setting transition (sol to gel) in the 
concentrated systems described in this thesis, as opposed to the dilute solution 
behavior described in Briscoe et al [6].  The temperature-related increase in viscosity 
can be seen to have a greater affect when there is a greater polymer concentration in 
the system, suggesting a tighter network for both PVA and PEG components.
7.5 Setting Behavior at a Range of Compositions 
7.5.1 Introduction
In order to correlate gel viscosity with final composition of samples, formulations 
previously described for composition (Table 5.4) were subjected to viscosity vs. 
temperature testing on the AR2000 rheometer.  Results in the following section 
compare gel composition with setting characteristics, with the objective of
minimizing pre-setting viscosity and maximizing the viscosity of the post-setting 
state.
7.5.2 Experimental
Temperature ramps from 95°C to 37°C were performed over 20 minutes using the 
same methods as described above (samples were tested using parallel crosshatched 
plates in oscillatory shear at 0.5% strain/s). Formulations are F1-145/10, as well as 
±3% and ±5% PEG, as described in Table 5.4.  Initial and final formulations are 
shown in a ternary diagram in Figure 7.11.  Viscosity curves were obtained, data was 
averaged and compared for viscosities at the pre- and post-setting states.
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7.5.3 Results/Discussion
Viscosity-temperature relationships for varying compositions are shown in Figure 
7.12.  Increasing PEG content showed an increase in setting transition.  Figure 7.13
shows the relationship between PEG in feed and the pre- and post-setting viscosities.  
There is a generally increasing trend in viscosity for all formulations.  The deviation 
from the trend for “minus 5%” samples is due to a slightly higher PVA content in the 
initial formulation as well as the gel (see Table 7.2).  The viscous contribution of 
PVA begins to dominate at these low PEG concentrations.  
The difference between post-setting and pre-setting viscosity is greatest for samples 
with larger amounts of PEG in the feed solution.  As post-setting viscosity increases, 
however, so does pre-setting viscosity, so a balance must be obtained between the 
desired post-set viscosity and a pre-set viscosity that allows for adequate workability.  
Based on preliminary injection testing, 8000Pa*s was chosen as a point where the 
solution becomes unworkable.  Approximate temperatures where each formulation 
crosses this point are listed in Table 7.3.  
For a low %PEG in the feed, the water content in the gel is high, which decreases the 
post-setting viscosity.  Pre-setting viscosity for these samples is high due to increased 
PVA content. An ideal setting formulation would have a low pre-setting viscosity and 
a high post-setting viscosity, such as is exhibited by formulations “F1-145/10” and 
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“+3% PEG”.  +5% PEG also produced favorable results, though high pre-setting 
viscosities may be prohibitive for delivery.
7.6 PEG Molecular Weight Affect on Gelation
7.6.1 Introduction
It was shown by Lim [5] that PEG molecular weight has an affect on the 
plasticization and general rheological properties of PVA solutions.  Higher degrees of 
plasticization were exhibited by lower molecular weight PEG (0.4kDa, when 
compared with 1.5kDa).  The reasoning provided was a reduction in hydrogen 
bonding between vinyl alcohol units (the polymer tested for the study by Lim was 
polyvinyl butyral).  FT-IR was used for characterization of this behavior.  It was 
found that the suspension viscosity decreased with decreasing PEG molecular weight.  
Glass transition temperature, as identified by DSC, was lower for lower PEG 
molecular weight, as well.  Samples were reported to also have become more ductile 
for low molecular weights.  An objective of the following study is to define the 
setting response of the PVA gel network that results from the incorporation of a range 
of PEG molecular weights.  A further objective is to test the Lim hypothesis of 
interference of hydrogen bonding in vinyl alcohol units in the case of the nucleus 
replacement system being evaluated.
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7.6.2 Experimental
A single phase formulation (i.e. initial and final compositions are same) is prepared 
(Formulation “G”, as described in Table 5.5) for formulations having an identical 
PVA molecular weight, but each sample type having different PEG molecular 
weights (0.4, 1, 10, & 20kDa).  This is the identical sample set as previously 
described in the swelling and stability section.  Standard sample preparation 
techniques were used, and rheometry testing was performed in the standard manner:
Samples had been autoclaved prior to testing, and allowed to sit for 5 minutes in a 
75°C bath prior to testing.  Samples were tested on an AR2000 rheometer, and were 
equilibrated at 95°C for 5 minutes on the rheometer platen (Peltier plate, with 40mm 
stainless steel crosshatched platens) before testing.  Testing was performed via 
oscillatory shear at 0.5% strain.  For analysis, temperature was ramped from 95 to 
37°C over 20 minutes to simulate implant cooling to physiologic temperature from 
the temperature at which it was made flowable.
7.6.3 Results/Discussion
Formulation G was prepared with five different molecular weights of PEG.  
Molecular weights 0.4, 1, 10 and 20 kDa are shown in Figure 7.14.  35kDa values 
were also tested and proved to be close to 20kDa, suggesting the effect of molecular 
size had reached a maximum.  Data represents average complex viscosity (n=4).   
Figure 7.14 also shows the reduction in viscosity at high temperatures, in samples 
containing the higher molecular weight PEG.  Both 1 and 10kDa can be seen to have 
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lower viscosities in the sol, when compared with 0.4 kDa.  An incline is clearly 
visible in the graph for 10kDa, at below 42°C, where the material transitions from the 
low viscosity high temperature state, to the high viscosity, low temperature state.  
When greater molecular weights of PEG are incorporated (see Figure 7.14), the 
transition in viscosity is seen to grow, as greater molecular weights of PEG increase 
the strength of the PVA/PEG network.  Results for incorporation of both 20kDa and 
35kDa were very close and it is possible that the effect of molecular size has reached 
a maximum at 20kDa.  When compared with the results of Briscoe [6], the 
corresponding greater transition of the PVA/PEG system with higher molecular 
weight PEG results from a greater incompatibility between the polymers, as was 
described for polymers having lower degree of hydrolysis or greater amounts of 
hydrophobic material.  The resulting effect in production of an increasing transition 
size is related to both the incorporation of a greater molecular weight polymer to the 
structure, which dictates how high the low temperature viscosity will extend, as well 
as the decreased interaction of PVA and water via the PEG in solution, which dictates 
the extent of plasticization and high temperature viscosity reduction.  
The change in equilibrium water content of the gels upon implantation must be 
considered in conjunction with the setting characteristics observed here, as greater 
water contents will result in weaker gels.  In other words, a greater setting transition 
alone will not provide a stronger gel if there is a significant change in water content 
upon equilibration with the implantation site.  Increased swelling of the PEG results 
in a less stable gel when samples are immersed in de-ionized water.  This is not a
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clear indication of behavior in an environment such as the intervertebral disc, 
however.
Using the same rheometry testing method, setting for the F1 formulation with 0.4kDa 
PEG was also determined.  Samples with 0.4kDa PEG could be seen to have a steady 
increase in viscosity similar to samples not containing PEG (see Figure 7.15).  Both 
lacked the setting transition displayed by samples having 10kDa PEG.  
It was also observed that samples containing lower molecular weights of PEG had a 
greater loss in polymer mass (see Chapter 6 for general stability and mass loss 
trends).  Samples containing PEG molecular weights at 0.4kDa were observed to 
elute greater than 35% of their polymer mass which suggests that the PEG may be 
eluting with the supernatant.  It is likely that any plasticization effect brought about 
by PEG as seen in Lim et al, is lessened by this elution.  Conversely, higher 
molecular weight PEG (10kDa) has been observed to be retained within gels, as 
evidenced by the NMR data for the ternary phase diagram prepared in this thesis.   
The presence of PEG in gels is suggested as the source of the high temperature 
viscosity reduction in the higher molecular weight PEG formulations.    
7.7 Calorimetric Studies for the Identification of Gel Point 
7.7.1 Experimental 
DSC was performed in order to locate gel point, corresponding to the presence of 
physical crosslinking in gels of the F1-145/10 formulation.  A descending 
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temperature ramp is designed to mimic the behavior of samples cooling from the melt 
as a result of injection from the ratchet gun delivery device. Test method steps are as 
follows:
1. Equilibrate at 25°C
2. Temperature jump: 25°C to 95°C.  
3. Temperature ramp 5°C/min to 37°C
4. Temperature ramp to 95°C.
7.7.2 Results/Discussion
Test runs showed no peaks.  No transition was observed in either descending or 
ascending ramp (see Figure 7.16) within the region described as the gel point.  These 
results suggest that the formation of any physical crosslinks in gels is not through a 
uniform crystallization.  The absence of a uniform peak suggests that physical 
crosslinking from uniform crystallinity that melts and reforms as a result of phase 
separation and spinodal decomposition as described in Ruberti et al is unlikely[77].  
Results from physically crosslinked PVA gels, such as those prepared via freeze-thaw 
methods show an endotherm peak that is produced from the melting out of 
crystallites.  DSC results suggest that a non-uniform physical hydrogen bonded 
association is responsible for the network and resulting high viscosity.  In other 
words, at low temperatures, once the viscosity reduction is no longer occurring, the 
effects of PVA concentration are again able to manifest in high viscosities.  
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Table 7.1 Feed formulations prepared at a range of PEG contents (quantities are in 
mmol).
Variables
Control A B C D E
Composition 
variables
PEG         
(0.0)
 PEG 
(1.0) 
PEG 
(0.80)
PEG 
(0.40)
PEG 
(0.09)
PEG 
(0.045)
PEG (10kDa) 0 0.080 0.16 0.71 1.42 1.77
PVA (Mowiol 
28-99)
0.138 0.138 0.138 0.138 0.138 0.138
DI Water 3050 3050 3050 3050 3050 3050
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Table 7.2 Viscosity relationships, pre- and post-setting.
Sample Type (% PEG in Feed)
-5% PEG -3% PEG F1-145/10 +3% PEG +5% PEG
Viscosity Pre-
Set (Pa*s@45C) 7880 5040 6040 7330 10770
Viscosity Post-
Set (Pa*s@37C) 18920 13950 21620 23690 31240
∆|η*| (Post 
minus Pre 
Setting 
Viscosities) 
(Pa*s) 11040 8910 15580 16360 20470
185
Table 7.3  Approximate temperatures at which viscosity crosses 8000 Pa*s.
Sample Type (% in Feed)
-5% PEG -3% PEG F1-145/10 +3% PEG +5% PEG
Injection Limit 
Temperature 
(°C) 45.0 40.0 42.5 45.0 47.5
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Figure 7.1 Closeup of a gel between two parallel plates on rheometer, crosshatching 
is visible at lower right.
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Figure 7.2 A curve representing average of modulus data (n=5) for F1-145/10.  
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Figure 7.3 Temperature response of viscosity when samples are subjected to a 
controlled cool from the sol (samples contain PEG; n=4)
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Figure 7.4 Complex viscosity vs. temperature for the F1-145/10 formulation (hollow 
circles) in comparison to that same formulation without the PEG plasticizer (solid 
circles).
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Figure 7.5 Curves showing viscosity change with time at varying hold temperatures.
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Figure 7.6 Viscosity vs. time data for three constant temperature steps (n=2).
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Figure 7.7 The feed formulations referenced in Table 7.1 trace a line across the 
binodal as shown above.  Three formulations prepared in the single phase region are 
also included (F-H, Table 5.5)
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Figure 7.8 Plasticization from small amounts of added PEG.  Data presented are 
averages (n=3).
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Figure 7.9 Gels after phase separation. A steep transition in viscosity can be seen for 
these samples at low temperatures.  This is in comparison to samples below the point 
of supernatant formation (Figure 7.8).  |n*| is average complex viscosity in all cases 
(n=3).
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Figure 7.10 Single phase gels. |n*| is average complex viscosity in all cases (n=1).
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Figure 7.11 Feed compositions and Final compositions on a ternary diagram.  
Dehydration produces lower water contents for greater PEG in the feed.
Initial Formulation
Final Formulation
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Figure 7.12 Viscosity for varying PEG concentrations in the feed.  The -5% PEG 
sample set is omitted for simplicity 
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Figure 7.15 Setting transitions for the F1 formulation with 0.4kDa ( ) and 10kDa 
( ) PEG.  Also included is the PVA gel without PEG ( ) for comparison
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Figure 7.16 DSC analysis used to mimic gel delivery system: 1. Temperature jump to 
95°C; 2. descending ramp and 3. an added ascending ramp (5°C/min).
202
LIST OF REFERENCES
1. Coventry, M.B.e.a., The intervertebral disc: it's microscopic anatomy and 
pathology.  Part II. Changes in the intervertebral disc concomitant with age.
J. Bone Joint Surg., 1945. 27(227-247).
2. Goins, M.L., et al., Nucleus pulposus replacement: an emerging technology.
Spine J, 2005. 5(6 Suppl): p. 317S-324S.
3. Darwis, D., et al., Characterization of poly(vinyl alcohol) hydrogel for 
prosthetic intervertebral disc nucleus. Radiation Physics and Chemistry, 
2002. 63: p. 539-542.
4. Inamura, I., Liquid-liquid phase separation and gelation in the poly(vinyl 
alcohol)-poly(ethylene glycol)-water system.  Dependence on molecular 
weight of poly(ethylene glycol). Polymer Journal, 1986. 18(3): p. 269-272.
5. Lim, L.Y.e.a., The Effect of Plasticizers on the Properties of Polyvinyl 
Alcohol Films. Drug Development and Industrial Pharmacy, 1994. 20(6): p. 
1007-1020.
6. Briscoe, B.e.a., The effects of hydrogen bonding upon the viscosity of aqueous 
poly(vinyl alcohol) solutions. Polymer, 1999. 41(3851-3860).
7. Gray, H., F.R.S., Anatomy, Descriptive and Surgical, ed. T.P.a.H. Pick, R. 
1901: Running Press.
8. White, A.A. and M.M. Panjabi, Clinical Biomechanics of the Spine. 2nd ed. 
1990, Philadelphia, PA: Lippincott Williams & Wilkins.
9. Keaveny, T.M.a.B., J M, Chapter 4. Biomechanics of Vertebral Bone, in Spine 
Technology Handbook, K.S.M.a.E.A. A, Editor. 2006, Elsevier.
10. Diwan, A.D.e.a., Current Concepts in Intervertebral Disk Restoration. Tissue 
Engineering in Orthopedic Surgery, 2000. 31(3): p. 453-464.
11. Nachemson, A. and J.M. Morris, In Vivo Measurements of Intradiscal 
Pressure. Discometry, a Method for the Determination of Pressure in the 
Lower Lumbar Discs. J Bone Joint Surg Am, 1964. 46: p. 1077-92.
12. Eyre, D.R., Biochemistry of the Intervertebral Disc. Int. Rev. Connect. Tissue 
Res., 1979. 8: p. 227-291.
203
13. Guerin, H.A.a.E., DM, Chapter 3 - Structure and Properties of Soft Tissues in 
the Spine, in Spine Technology Handbook, K.S.M.a.E.A. A, Editor. 2006, 
Elsevier. p. 37.
14. Sieber, A.N.e.a., Concepts in Nuclear Replacement. The Spine Journal, 2004. 
4(2004): p. 322S-324S.
15. Martinez, J., V. Oloyede, and N. Broom, Biomechanics of load-bearing of the 
intervertebral disc: an experimental and finite element model. Medical 
engineering & physics, 1997. 19: p. 145-56.
16. Urban, J.P., The role of the physicochemical environment in determining disc 
cell behaviour. Biochem Soc Trans, 2002. 30(Pt 6): p. 858-64.
17. Urban, J.P. and A. Maroudas, Swelling of the intervertebral disc in vitro.
Connect Tissue Res, 1981. 9(1): p. 1-10.
18. Urban, J.P., et al., Swelling pressures of proteoglycans at the concentrations 
found in cartilaginous tissues. Biorheology, 1979. 16(6): p. 447-64.
19. Urban, J., S. Roberts, and J.R. Ralphs, The nucleus of the Intervertebral disc 
from development to degeneration. American Zoologist, 2000. 40: p. 53-61.
20. Shiradzi-Adl, A.a.D., G, Load bearing role of facets in a segment under 
sagittal plane loadings. J. Biomech. Eng, 1987. 20(6): p. 601.
21. Wilke, H., et al., Intradiscal pressure together with anthropometric data--a 
data set for the validation of models. Clin Biomech (Bristol, Avon), 2001. 16 
Suppl 1: p. S111-26.
22. Simunic, D.I., N.D. Broom, and P.A. Robertson, Biomechanical factors 
influencing nuclear disruption of the intervertebral disc. Spine, 2001. 26(11): 
p. 1223-30.
23. Allen, M.J., et al., Preclinical Evaluation of a Poly (Vinyl Alcohol) Hydrogel 
Implant as a Replacement for the Nucleus Pulposus. Spine, 2004. 29(5): p. 
515-523.
24. Thomas, J., et al., The effect of dehydration history on PVA/PVP hydrogels for 
nucleus pulposus replacement. J Biomed Mater Res B Appl Biomater, 2004. 
69B(2): p. 135-40.
25. Bibby, S.R., et al., The pathophysiology of the intervertebral disc. Joint Bone 
Spine, 2001. 68(6): p. 537-42.
204
26. Adams, M.A. and P. Dolan, Recent advances in lumbar spinal mechanics and 
their clinical significance. Clin Biomech (Bristol, Avon), 1995. 10(1): p. 3-19.
27. Bertagnoli, R., et al., Mechanical testing of a novel hydrogel nucleus 
replacement implant. Spine J, 2005. 5(6): p. 672-81.
28. Jin, D., et al., Prosthetic disc nucleus (PDN) replacement for lumbar disc 
herniation: preliminary report with six months' follow-up. J Spinal Disord 
Tech, 2003. 16(4): p. 331-7.
29. Frei, H., et al., The effect of nucleotomy on lumbar spine mechanics in 
compression and shear loading. Spine, 2001. 26(19): p. 2080-9.
30. Adams, M.A. and W.C. Hutton, Gradual disc prolapse. Spine, 1985. 10(6): p. 
524-31.
31. Adams, M.A., P. Dolan, and W.C. Hutton, The stages of disc degeneration as 
revealed by discograms. J Bone Joint Surg Br, 1986. 68(1): p. 36-41.
32. White, A.A.a.G., S L, Synopsis: Workshop on idiopathic low back pain.
Spine, 1982. 7: p. 141.
33. Wyke, B., The neurological basis of thoracic spine pain. Rheumatol. Phys. 
Med., 1970. 10: p. 356.
34. Sagi, H.C., Q.B. Bao, and H.A. Yuan, Nuclear replacement strategies. Orthop 
Clin North Am, 2003. 34(2): p. 263-7.
35. Bao, Q.B., et al., The artificial disc: theory, design and materials.
Biomaterials, 1996. 17(12): p. 1157-67.
36. Falagas, M.E. and S.K. Kasiakou, Mesh-related infections after hernia repair 
surgery. Clin Microbiol Infect, 2005. 11(1): p. 3-8.
37. Bao, Q.B. and H.A. Yuan, Prosthetic disc replacement: the future? Clin 
Orthop, 2002(394): p. 139-45.
38. Pope, M., V. Boel, and D. Sumner, Biomechanics of Fusion and Stabilization.
Spine, 1995. 20(24): p. S85-S99.
39. Davis, G.W. and G. Onik, Clinical experience with automated percutaneous 
lumbar discectomy. Clin Orthop Relat Res, 1989(238): p. 98-103.
40. Meakin, J.R. and D.W. Hukins, Effect of removing the nucleus pulposus on 
the deformation of the annulus fibrosus during compression of the 
intervertebral disc. J Biomech, 2000. 33(5): p. 575-80.
205
41. Eysel, P., et al., Biomechanical behaviour of a prosthetic lumbar nucleus.
Acta Neurochir (Wien), 1999. 141(10): p. 1083-7.
42. Villarraga, M., Chapter 7. Historical Review of Spinal Instrumentation for 
Fusion. Spine Technology Handbook, ed. S.M.a.E.A.A. Kurtz. 2006: Elsevier.
43. McKay, B.e.a., Chapter 9. Biologics to Promote Spinal Fusion. Spine 
Technology Handbook, ed. S.M.a.E.A.A. Kurtz. 2006: Elsevier.
44. Zigler, J.E., Lumbar spine arthroplasty using the ProDisc II. Spine J, 2004. 
4(6 Suppl): p. 260S-267S.
45. Nachemson, A., Lumbar intradiscal pressure. Experimental studies on post-
mortem material. Acta Orthop Scand, 1960. Suppl 43: p. 1-104.
46. Carl, A., et al., New developments in nucleus pulposus replacement 
technology. Spine J, 2004. 4(6 Suppl): p. 325S-329S.
47. Boyd, L.M. and A.J. Carter, Injectable biomaterials and vertebral endplate 
treatment for repair and regeneration of the intervertebral disc. Eur Spine J, 
2006. 15 Suppl 15: p. 414-21.
48. A Prospective, Multicenter Pilot Study of the Disc Dynamics DASCOR
TM
 Disc 
Arthroplasty System in the Treatment of Degenerative Disc Disease. [website]  
[cited 2007 25 Jul]; Available from: http://www.discdyn.com/pdf/US-101.pdf.
49. Ahrens, M., et al., Nucleus Replacement with an in situ Curable Balloon 
Contained Polymer and Restoration of Segmental Kinematics. European cells 
& materials, 2005. 10(Suppl. 3).
50. Ray, C.D., The artificial disc: Introduction, history, and socioeconomics, in 
Clinical Efficacy and Outcome in the Diagnosis and Treatment of Low Back 
Pain, J.N. Weinstein, Editor. 1992, Raven Press, Ltd.: New York. p. 205-225.
51. Klara, P.M. and C.D. Ray, Artificial nucleus replacement: clinical experience.
Spine, 2002. 27(12): p. 1374-7.
52. Ramseyer, P.e.a., Polyacrylonitrile-based hydrogel as a therapeutic bulking 
agent in urology. Biomaterials, 2007. 28(6): p. 1185-1190.
53. Lemaire, J.P.e.a., Intervertebral Disc Prosthesis - Results and Prospects for 
the Year 2000. Clinical Orthopaedics and Related Research, 1997. 337: p. 64-
76.
206
54. Saunders, K.J., Organic Polymer Chemistry - 2nd ed. 1988: Blackie 
Academic.
55. Wade, L.G., Organic Chemistry 5th ed. 2003, Upper Saddle River, NJ: 
Prentice Hall.
56. Lee, E.J.e.a., Rheological Properties of Solutions of General Purpose 
Poly(vinyl alcohol) in Dimethyl Sulfoxide. Journal of Polymer Science Part B: 
Polymer Physics, 2003. 42(8): p. 1451-1456.
57. Peppas, N.A. and E.W. Merrill, Poly(vinyl alcohol) hydrogels: Reinforcement 
of radiation-crosslinked networks by crystallization. Journal of polymer 
science - Polymer chemistry edition, 1976. 14: p. 441-457.
58. Peppas, N.A. and N.K. Mongia, Ultrapure poly(vinyl alcohol) hydrogels with 
mucoadhesive drug delivery characteristics. Eur J Pharm Biopharm, 1997. 43: 
p. 51-58.
59. Peppas, N.A., Infrared spectroscopy of semicrystalline poly(vinyl alcohol) 
networks. Die Makromolekulare Chemie, 1977. 178: p. 595-601.
60. Onogi, S.e.a., Time-Humidity Superposition in Some Crystalline Polymers 
Journal of Polymer Science, 1962. 58: p. 1-17.
61. Hyon, S.-H.e.a., US Pat. 4,663,358 - Porous and Transparent Poly(vinyl 
alcohol) Gel and Method of Manufacturing the Same. 1987.
62. Hoffman, A., Hydrogels for biomedical applications. Advanced Drug 
Delivery Reviews, 2002. 43: p. 3-12.
63. Odian, G., Principles of Polymerization. p. 574, 748.
64. Hermanson, G.T., Bioconjugate Techniques 2nd ed. 2008: Elsevier.
65. Peppas, N.A.a.M.E.W., Crosslinked Poly(vinyl alcohol) Hydrogels as Swollen 
Elastic Networks. Journal of Applied Polymer Science, 1977. 21: p. 1763-
1770.
66. Zhang, X.e.a., Double network hydrogel with high mechanical strength 
prepared from two biocompatible polymers. Journal of Applied Polymer 
Science, 2009. 112: p. 3063-3070.
67. Lozinsky, V., Cryotropic gelation of poly(vinyl alcohol) solutions. Russian 
Chemical Reviews, 1998. 67(7): p. 573-586.
207
68. Stammen, J.A., et al., Mechanical properties of a novel PVA hydrogel in shear 
and unconfined compression. Biomaterials, 2001. 22(8): p. 799-806.
69. Fabula, A.G., Proc. Fourth Intern Congr. Rheol., Part 3. 1965. p. 189.
70. Rodriquez, F., Principles of Polymer Systems, 4th ed., ed. T.a. Francis. 1989.
71. Ratner, B.D.e.a., Biomaterials Science. 1996: Elsevier.
72. Gregonis, D.e.a., Poly(ethylene glycol) surfaces to minimize protein 
absorption. . Trans. Sec. World Conr. Biomater. , 1984 7:: p. 266.
73. Flory, P.J., Principles of Polymer Chemistry, ed. Cornell. 1953.
74. Borzacchiello, A.a.A., L., Structure Property Relationships in Hydrogels. 
Hydrogels - Biological Properties and Applications, ed. R. Barbucci. 2009, 
Milan: Springer.
75. Toyoshima, K., Poly(vinyl alcohol), ed. C.A. Finch. 1973: Wiley Interscience. 
535.
76. Inamura, I.e.a., Effects of Molecular Weight on the Phase Equilibrium of a 
Poly(vinyl alcohol)-Poly(ethylene glycol)-Water System. Polymer Journal, 
1984. 16(8): p. 657-660.
77. Ruberti, J.e.a., Systems and Methods for Controlling and Forming Polymer 
Gels. 2009.
78. Oral, E.e.a., Vitamin C hinders radiation crosslinking in aqueous poly(vinyl 
alcohol) solutions. Nuclear Instruments and Methods in Physics Research B, 
2007(265): p. 92-97.
79. Llanos, G.R.a.S., M.V., Immobilization of Poly(ethylene Glycol onto a 
Poly(vinyl alcohol) Hydrogel.  1. Synthesis and Characterization.
Macromolecules, 1991. 24: p. 6065-6072.
80. Chang, J.Y.e.a., Biopolymers/PVA Hydrogels/Anionic 
Polymerisation/Nanocomposites: Springer.
81. Tanaka, Y.e.a., Prog. Polym. Sci., 2005. 30: p. 1.
82. TsingHua, Toxicity and healing effect of PEO/PVA hydrogels as wound 
dressings. Journal of Radiation Research and Radiation Processing, 2000.
83. Yoshii, F.e.a., Electron beam crosslinked PEO and PEO/PVA hydrogels for 
wound dressing. Radiation Physics and Chemistry, 1999. 55(2): p. 133-138.
208
84. Cruise, e.al  United States Patent Application 20090028945.
85. Ash, Handbook of Fillers, Extenders, Diluents.
86. Harris, J.M., Poly(ethylene Glycol) Chemistry: Biotechnical and Biomedical 
Applications.
87. Chiropractors, D.   2010; Available from: 
http://www.mountainviewpaincenter.com/wp-
content/uploads/2010/02/lumbar_disc_herniation2.jpg.
88. Chiu, J.e.a., Posterolateral endoscopic thoracic microcompressive 
discectomy. The internet journal of minimally invasive spinal technology.
89. Assocs., B.N. Lumbar Fusion.  2010; Available from: 
http://www.bnasurg.com/patient-resources-back-pain.php.
90. USSynthesProdisc.com, Prodisc Lumbar Total Disc Replacement.
91. SpineUniverse.com. Acroflex Total Disc.  2010; Available from: 
spineuniverse.com.
92. An, H.S. Artificial Disc Replacement.
93. Tompa, H., Trans. Faraday Soc., 1949. 45: p. 1142.
94. Bamford, C.H.a.T., H. , Trans. Faraday Soc., 1950. 46: p. 310.
95. Lozinsky, V.I., et al., Study of cryostructuration of polymer systems.  XII. 
Poly(vinyl alcohol) cryogels: Influence of low-molecular electrolytes. Journal 
of Applied Polymer Science, 1996. 61: p. 1991-1998.
96. Thomas, J., A. Lowman, and M. Marcolongo, Novel associated hydrogels for 
nucleus pulposus replacement. J Biomed Mater Res, 2003. 67A(4): p. 1329-
37.
97. Szymanski, H.A.a.Y., R E, NMR Band Handbook, ed. IFI/Plenum. 1968, New 
York.
98. Painter, P.a.C., M., Fundamentals of Polymer Science: An Introductory Text, 
First Edition. 1996: Wiley Interscience.
99. Muller, R.e.a., POLYMER NETWORKS. 2006.
209
100. ASTM, Standard Test Method for Plastics: Dynamic Mechanical Properties: 
Cure Behavior, in 4473 
101. Dealy, J.a.W., K, Melt Rheology and Its Role in Plastics Processing. 1995, 
London: Chapman and Hall.
210
VITA
Kristin Benjamin Kita was born in Doylestown, Pennsylvania on December 15, 1974.  
He was introduced to the science of polymers while enrolled at the Pennsylvania 
State University by Dr. Paul Painter, who became his advisor in the program.  His 
undergraduate research pertained to hydrogen bonding and crystallization of 
polyamides.  In 1998 he completed his B.S. in Materials Engineering with an option 
in Polymer Science.  After graduation, he worked with both the development of 
pharmaceutical suspensions at McNeil Consumer Healthcare, as well as 
pharmaceutical product release at Cardinal Healthcare, both in southeastern 
Pennsylvania.  He was enrolled in graduate school for Materials Engineering at 
Drexel University in 2003 to study implantable biomaterials, and funded his 
education through employment at Gelifex, Inc., a startup company founded by local 
entrepreneurs, Drexel professors, and a spine surgeon.  In this position he developed 
poly(vinyl alcohol) and poly(n-isopropylacrylamide) hydrogel nucleus replacement 
technologies.  The company was sold to Synthes Spine, Inc. where Kristin assisted in 
bringing the major Gelifex nucleus replacement product to clinical trials.  During his 
Synthes employment, Kristin authored several patent applications ranging from 
bioadhesive hydrogels to hydrogels crosslinked via novel methods.  He spent years as 
a scientist at Synthes developing in-situ curing poly(vinyl alcohol) hydrogels by both 
chemical and physical crosslinking techniques.  In 2008, Kristin was awarded the 
Synthes Spine innovation award for his work in nucleus replacement.  Kristin 
defended his Ph.D. on December 9, 2010. 

2
